Pediatrix Medical Group, Inc. (MD)
Sunrise, FL, US
Pediatrix Medical Group, Inc. delivers specialized medical services for newborns, expectant mothers, and pediatric patients across the United States and Puerto Rico. The company offers crucial neonatal care to critically ill or prematurely born infants within hospital units, staffed by expert neonatal subspecialists and advanced practice clinicians. For pregnant individuals and their developing babies, Pediatrix provides comprehensive maternal-fetal medicine services in both clinical and inpatient settings, involving specialists such as maternal-fetal medicine physicians, obstetricians, and genetic counselors. Furthermore, the group delivers pediatric cardiology services, addressing both congenital and acquired heart conditions in patients ranging from the fetal stage through adulthood, under the care of dedicated pediatric cardiologists. Beyond these core areas, Pediatrix extends its expertise to various other pediatric subspecialties, including those requiring intensivists, surgeons, and ophthalmologists, and supplies vital support to hospital departments like emergency rooms and labor and delivery units. Established in 1979 in Sunrise, Florida, and formerly known as MEDNAX, Inc. until its renaming in July 2022, the company managed a network of approximately 2,700 physicians as of February 2022.
| Target company | Date | Filing |
|---|---|---|
| Magella | 2001-03-16 | View |
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.60% | +5.41% | +8.95% | +10.92% | +3.00% | +9.26% | +62.74% | +68.74% | -23.90% | -65.98% | +337.33% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 2 | 0 |
| Hold | 5 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | 1 |
27.00
+3.3%
|
| Last Quarter | 4 |
22.25
-14.9%
|
| Last Year | 7 |
21.86
-16.4%
|
| All Time | 16 |
20.63
-21.1%
|
-
Revenue growth Medical - Care Facilities: +10.2%-4.9% Q1'26: +3.9% (vs Q1'25)
-
EPS growth Medical - Care Facilities: +19.2%+263.0% ★ Q1'26: +50.0% (vs Q1'25)
-
FCF margin FCF growth · Medical - Care Facilities: +32.0%+11.0% Q1'26: -28.5% (vs Q1'25)
-
EBIT margin Medical - Care Facilities: +11.3%+13.2% ★ Q1'26: +9.9% (vs Q1'25)
-
ROIC Medical - Care Facilities: +6.8%+18.8% ★ Q1'26: +12.2% (vs Q1'25)
-
Share dilution Medical - Care Facilities: +0.0%+2.3% Q1'26: -3.2% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Care Facilities: 0.99×2.41× ★ Q1'26: 2.96× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2010 actual |
Dec 2011 actual |
Dec 2012 actual |
Dec 2013 actual |
Dec 2014 actual |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 5 Rev. Ana. 5 EPS Ana. |
Dec 2027 5 Rev. Ana. 5 EPS Ana. |
Dec 2028 3 Rev. Ana. 3 EPS Ana. |
Dec 2029 2 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
1.40B
est: 1.39B (+0.5%)
|
1.59B
est: 1.56B (+1.9%)
|
1.82B
est: 1.79B (+1.5%)
|
2.15B
est: 2.10B (+2.5%)
|
2.44B
est: 2.40B (+1.5%)
|
2.78B
est: 2.79B (-0.2%)
|
3.18B
est: 3.19B (-0.4%)
|
3.46B
est: 3.43B (+0.8%)
|
3.65B
est: 3.62B (+0.6%)
|
1.78B
est: 3.51B (-49.3%)
|
1.73B
est: 2.08B (-16.5%)
|
1.91B
est: 1.90B (+0.8%)
|
1.97B
est: 1.96B (+0.6%)
|
1.99B
est: 2.00B (-0.4%)
|
2.01B
est: 2.00B (+0.8%)
|
1.91B
est: 1.90B (+0.5%)
|
1.94B
1.93B – 1.95B
+1.7% YoY
|
1.98B
1.95B – 2.00B
+2.4% YoY
|
2.07B
2.07B – 2.07B
+4.2% YoY
|
2.22B
2.19B – 2.24B
+7.3% YoY
|
| EBITDA |
336.30M
est: 334.58M (+0.5%)
|
382.18M
est: 375.13M (+1.9%)
|
422.23M
est: 414.98M (+1.7%)
|
492.10M
est: 481.08M (+2.3%)
|
558.99M
est: 554.55M (+0.8%)
|
622.10M
est: 576.05M (+8.0%)
|
660.95M
est: 679.38M (-2.7%)
|
587.86M
est: 593.27M (-0.9%)
|
527.69M
est: 564.06M (-6.4%)
|
203.64M
est: -1.41B (+114.5%)
|
146.07M
est: -892.02M (+116.4%)
|
236.10M
est: 213.99M (+10.3%)
|
156.70M
est: 193.46M (-19.0%)
|
29.89M
est: 139.04M (-78.5%)
|
-28.37M
est: 138.64M (-120.5%)
|
274.22M
est: 132.26M (+107.3%)
|
134.55M
133.86M – 135.25M
+1.7% YoY
|
137.79M
135.72M – 139.16M
+2.4% YoY
|
143.60M
143.60M – 143.60M
+4.2% YoY
|
154.09M
152.39M – 155.49M
+7.3% YoY
|
| EBIT |
314.35M
est: 311.30M (+1.0%)
|
356.88M
est: 348.86M (+2.3%)
|
391.42M
est: 382.79M (+2.3%)
|
452.13M
est: 440.48M (+2.6%)
|
513.00M
est: 504.79M (+1.6%)
|
557.87M
est: 511.92M (+9.0%)
|
571.69M
est: 582.74M (-1.9%)
|
460.23M
est: 484.25M (-5.0%)
|
443.85M
est: 442.07M (+0.4%)
|
177.71M
est: -1.13B (+115.7%)
|
117.63M
est: 129.66M (-9.3%)
|
203.95M
est: 168.02M (+21.4%)
|
121.07M
est: 198.52M (-39.0%)
|
-6.28M
est: 106.82M (-105.9%)
|
-60.60M
est: 106.52M (-156.9%)
|
252.40M
est: 101.62M (+148.4%)
|
103.38M
102.84M – 103.91M
+1.7% YoY
|
105.86M
104.27M – 106.92M
+2.4% YoY
|
110.33M
110.33M – 110.33M
+4.2% YoY
|
118.39M
117.08M – 119.46M
+7.3% YoY
|
| Net Income |
202.69M
est: 201.72M (+0.5%)
|
218.00M
est: 214.00M (+1.9%)
|
240.91M
est: 236.75M (+1.8%)
|
280.52M
est: 273.23M (+2.7%)
|
317.28M
est: 312.17M (+1.6%)
|
336.32M
est: 308.79M (+8.9%)
|
324.91M
est: 331.20M (-1.9%)
|
320.37M
est: 319.10M (+0.4%)
|
268.63M
est: 266.36M (+0.9%)
|
-1.50B
est: -1.51B (+1.1%)
|
-796.49M
est: -1.09B (+27.1%)
|
130.96M
est: 107.65M (+21.7%)
|
66.34M
est: 82.66M (-19.8%)
|
-60.41M
est: -259.32M (+76.7%)
|
-99.07M
est: 109.92M (-190.1%)
|
165.39M
est: 174.22M (-5.1%)
|
197.47M
192.13M – 202.81M
+13.3% YoY
|
202.51M
191.08M – 213.94M
+2.5% YoY
|
193.46M
179.42M – 207.51M
-4.5% YoY
|
174.80M
172.29M – 176.87M
-9.6% YoY
|
| SGA |
154.27M
est: 153.50M (+0.5%)
|
170.36M
est: 167.04M (+2.0%)
|
193.54M
est: 190.56M (+1.6%)
|
218.21M
est: 212.72M (+2.6%)
|
247.53M
est: 243.67M (+1.6%)
|
305.92M
est: 280.59M (+9.0%)
|
372.57M
est: 379.55M (-1.8%)
|
417.11M
est: 421.84M (-1.1%)
|
432.38M
est: 428.24M (+1.0%)
|
244.51M
est: 407.23M (-40.0%)
|
248.95M
est: 384.74M (-35.3%)
|
263.36M
est: 218.72M (+20.4%)
|
231.40M
est: 227.32M (+1.8%)
|
227.54M
est: 245.69M (-7.4%)
|
238.44M
est: 244.99M (-2.7%)
|
240.79M
est: 233.72M (+3.0%)
|
237.77M
236.54M – 239.00M
+1.7% YoY
|
243.48M
239.83M – 245.92M
+2.4% YoY
|
253.75M
253.75M – 253.76M
+4.2% YoY
|
272.29M
269.28M – 274.77M
+7.3% YoY
|
| EPS |
2.17
est: 2.00 (+8.5%)
|
2.23
est: 2.16 (+3.2%)
|
2.41
est: 2.34 (+3.0%)
|
2.77
est: 2.64 (+4.9%)
|
3.30
est: 3.07 (+7.5%)
|
3.59
est: 4.06 (-11.6%)
|
3.47
est: 4.05 (-14.3%)
|
3.42
est: 3.30 (+3.5%)
|
2.95
est: 3.80 (-22.4%)
|
-17.78
est: 3.37 (-627.7%)
|
-9.31
est: 1.23 (-858.9%)
|
1.52
est: 1.53 (-0.8%)
|
0.80
est: 1.69 (-52.7%)
|
-0.72
est: -3.04 (+76.4%)
|
-1.19
est: 1.35 (-188.2%)
|
1.94
est: 2.08 (-6.9%)
|
2.28
2.25 – 2.38
+9.6% YoY
|
2.37
2.24 – 2.51
+3.7% YoY
|
2.30
2.10 – 2.43
-2.8% YoY
|
2.05
2.02 – 2.07
-11.0% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-11 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-08 | A | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-07 | A | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-06 | A | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-05 | A | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 4/5 | 3/5 |
| 2026-05-04 | A | 4/5 | 4/5 | 5/5 | 5/5 | 1/5 | 4/5 | 3/5 |
| 2026-05-01 | A | 4/5 | 4/5 | 5/5 | 5/5 | 1/5 | 4/5 | 3/5 |
| 2026-04-30 | A | 4/5 | 4/5 | 5/5 | 5/5 | 1/5 | 4/5 | 3/5 |
| 2026-04-29 | A | 4/5 | 4/5 | 5/5 | 5/5 | 1/5 | 4/5 | 3/5 |
| 2026-04-28 | A | 4/5 | 4/5 | 5/5 | 5/5 | 1/5 | 4/5 | 3/5 |
| 2026-04-27 | A | 4/5 | 4/5 | 5/5 | 5/5 | 1/5 | 4/5 | 3/5 |
| 2026-04-24 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-23 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-22 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-21 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-20 | A | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-17 | A | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-16 | A | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-15 | A | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 3/5 | 3/5 |
Owner Earnings
Ownership Overview
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | (1) BlackRock, Inc. | 13.13M | 15.20% | 12.95M | — | 13.13M | — | HC | Delaware | 2022-01-27 | ↗ |
| 2 | 52-0556948 | 8.80M | 9.80% | 2.95M | — | 8.80M | — | IA | Maryland | 2019-02-14 | ↗ |
| 3 | David Rosen | 8.28M | 9.64% | — | 8.28M | — | — | IN | State of Delaware | 2024-11-13 | ↗ |
| 4 | LP | 8.28M | 9.64% | — | 8.28M | — | — | IA, PN | State of Delaware | 2024-11-13 | ↗ |
| 5 | 13-4064930 | 7.36M | 8.50% | 6.27M | — | 7.36M | — | IA | Delaware | 2022-02-14 | ↗ |
| 6 | Lazard Asset Management LLC | 6.99M | 11.00% | 5.03M | — | 6.99M | — | IA | Delaware | 2023-03-09 | ↗ |
| 7 | JEFFREY C. SMITH | 5.92M | 6.90% | — | — | — | 5.92M | IN | — | 2021-08-31 | ↗ |
| 8 | PETER A. FELD | 5.92M | 6.90% | — | — | — | 5.92M | IN | — | 2021-08-31 | ↗ |
| 9 | STARBOARD PRINCIPAL CO GP LLC | 5.92M | 6.90% | — | — | 5.92M | — | OO | — | 2021-08-31 | ↗ |
| 10 | STARBOARD PRINCIPAL CO LP | 5.92M | 6.90% | — | — | 5.92M | — | PN | — | 2021-08-31 | ↗ |
| 11 | STARBOARD VALUE GP LLC | 5.92M | 6.90% | — | — | 5.92M | — | OO | — | 2021-08-31 | ↗ |
| 12 | STARBOARD VALUE LP | 5.92M | 6.90% | — | — | 5.92M | — | PN | — | 2021-08-31 | ↗ |
| 13 | Abigail P. Johnson | 5.56M | 6.43% | — | — | 5.56M | — | IN | — | 2022-02-09 | ↗ |
| 14 | FMR LLC | 5.56M | 6.43% | 2.31M | — | 5.56M | — | HC | — | 2022-02-09 | ↗ |
| 15 | (. | 5.01M | 5.94% | 4.89M | — | 5.01M | — | IA | Delaware Limited Partnership | 2020-02-12 | ↗ |
| 16 | Edward C. Johnson 3d | 4.19M | 8.57% | — | — | 4.19M | — | IN | Delaware | 2012-02-14 | ↗ |
| 17 | 30-0447847 | 4.11M | 4.80% | 4.00M | — | 4.11M | — | IA | — | 2021-02-12 | ↗ |
| 18 | STARBOARD VALUE AND OPPORTUNITY MASTER FUND LTD | 3.24M | 3.80% | — | — | 3.24M | — | CO | — | 2021-08-31 | ↗ |
| 19 | ArrowMark Colorado Holdings, LLC | 2.68M | 3.10% | 2.68M | — | 2.68M | — | IA | — | 2022-02-14 | ↗ |
| 20 | Elliott International Capital Advisors Inc. | 1.29M | 1.40% | — | 1.29M | — | 10.00 | CO | Delaware | 2017-11-16 | ↗ |
| 21 | Elliott International, L.P. | 1.29M | 1.40% | — | 1.29M | — | 10.00 | PN | Cayman Islands, British West Indies | 2017-11-16 | ↗ |
| 22 | STARBOARD VALUE R GP LLC | 648.3K | 1.00% | — | — | 648.3K | — | OO | — | 2021-08-31 | ↗ |
| 23 | Elliott Associates, L.P. | 608.0K | 0.70% | 608.0K | — | 608.0K | 10.00 | PN | Delaware | 2017-11-16 | ↗ |
| 24 | STARBOARD VALUE AND OPPORTUNITY S LLC | 575.3K | 1.00% | — | — | 575.3K | — | OO | — | 2021-08-31 | ↗ |
| 25 | STARBOARD X MASTER FUND LTD | 457.3K | 1.00% | — | — | 457.3K | — | CO | — | 2021-08-31 | ↗ |
| 26 | STARBOARD VALUE AND OPPORTUNITY C LP | 334.4K | 1.00% | — | — | 334.4K | — | PN | — | 2021-08-31 | ↗ |
| 27 | STARBOARD VALUE R LP | 334.4K | 1.00% | — | — | 334.4K | — | PN | — | 2021-08-31 | ↗ |
| 28 | STARBOARD VALUE AND OPPORTUNITY MASTER FUND L LP | 313.9K | 1.00% | — | — | 313.9K | — | PN | — | 2021-08-31 | ↗ |
| 29 | STARBOARD VALUE L LP | 313.9K | 1.00% | — | — | 313.9K | — | PN | — | 2021-08-31 | ↗ |
Institutional Activity (13F)
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | BLACKROCK, INC. | 13.56M -287.0K (-2.1%) | 290.10M +58.1M (+25.1%) | 15.89% -0.058 pp | 0.00% +0.001 pp | USD11.63 +83.9% | 6 qtrs — |
| 2 | VANGUARD GROUP INC | 10.72M -168.6K (-1.5%) | 229.39M +46.9M (+25.7%) | 12.56% +0.021 pp | 0.00% +0.001 pp | USD29.36 -27.1% | 68 qtrs — |
| 3 | VICTORY CAPITAL MANAGEMENT INC | 3.82M -307.9K (-7.5%) | 81.67M +12.6M (+18.2%) | 4.47% -0.278 pp | 0.05% +0.006 pp | USD14.89 +43.7% | 32 qtrs — |
| 4 | AMERICAN CENTURY COMPANIES INC | 3.70M +1.0M (+37.8%) | 79.10M +34.2M (+76.0%) | 4.33% +1.243 pp | 0.04% +0.017 pp | USD16.16 +32.4% | 11 qtrs — |
| 5 | DIMENSIONAL FUND ADVISORS LP | 3.57M +169.4K (+5.0%) | 76.35M +19.4M (+34.1%) | 4.18% +0.267 pp | 0.02% +0.004 pp | USD31.01 -31.0% | 51 qtrs — |
| 6 | STATE STREET CORP | 3.31M -218.6K (-6.2%) | 70.85M +11.7M (+19.8%) | 3.88% -0.185 pp | 0.00% +0.000 pp | USD33.27 -35.7% | 51 qtrs — |
| 7 | FMR LLC | 2.43M +224.2K (+10.2%) | 51.95M +15.0M (+40.7%) | 2.85% +0.307 pp | 0.00% +0.001 pp | USD13.89 +54.0% | 68 qtrs — |
| 8 | GEODE CAPITAL MANAGEMENT, LLC | 2.18M +14.4K (+0.7%) | 46.67M +10.4M (+28.6%) | 2.56% +0.060 pp | 0.00% +0.001 pp | USD27.38 -21.9% | 68 qtrs — |
| 9 | D. E. SHAW & CO., INC. | 1.85M -169.1K (-8.4%) | 39.62M +5.8M (+17.0%) | 2.17% -0.158 pp | 0.02% +0.003 pp | USD17.62 +21.4% | 34 qtrs — |
| 10 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1.55M +105.3K (+7.3%) | 33.21M +9.0M (+37.0%) | 1.82% +0.152 pp | 0.01% +0.001 pp | USD22.42 -4.6% | 68 qtrs — |
| 11 | RENAISSANCE TECHNOLOGIES LLC | 1.36M +51.7K (+4.0%) | 29.04M +7.2M (+32.8%) | 1.59% +0.087 pp | 0.05% +0.016 pp | USD13.21 +61.9% | 12 qtrs — |
| 12 | MORGAN STANLEY | 1.30M +24.7K (+1.9%) | 27.89M +6.5M (+30.2%) | 1.53% +0.055 pp | 0.00% +0.000 pp | USD11.15 +91.8% | 51 qtrs — |
| 13 | FULLER & THALER ASSET MANAGEMENT, INC. | 1.23M +1.2M (+100.0%) | 26.30M +26.3M (+100.0%) | 1.44% +1.440 pp | 0.09% +0.089 pp | USD21.39 +0.0% | 1 qtrs NEW |
| 14 | NUVEEN, LLC | 1.20M -351.1K (-22.6%) | 25.67M -311.4K (-1.2%) | 1.41% -0.380 pp | 0.01% 0.000 pp | USD15.50 +38.0% | 4 qtrs — |
| 15 | INVESCO LTD. | 1.09M +213.6K (+24.4%) | 23.33M +8.6M (+58.8%) | 1.28% +0.268 pp | 0.00% +0.001 pp | USD16.95 +26.2% | 57 qtrs — |
| 16 | SILVERCREST ASSET MANAGEMENT GROUP LLC | 1.03M +1.0M (+100.0%) | 22.08M +22.1M (+100.0%) | 1.21% +1.209 pp | 0.15% +0.152 pp | USD21.39 +0.0% | 1 qtrs NEW |
| 17 | NORTHERN TRUST CORP | 872.3K -60.3K (-6.5%) | 18.66M +3.0M (+19.4%) | 1.02% -0.052 pp | 0.00% +0.000 pp | USD29.38 -27.2% | 51 qtrs — |
| 18 | ALLIANCEBERNSTEIN L.P. | 815.8K -24.1K (-2.9%) | 17.45M +3.4M (+24.0%) | 0.96% -0.011 pp | 0.01% +0.001 pp | USD21.49 -0.5% | 61 qtrs — |
| 19 | BOSTON PARTNERS | 797.7K -630.3K (-44.1%) | 17.20M -6.9M (-28.5%) | 0.93% -0.710 pp | 0.02% -0.007 pp | USD10.25 +108.7% | 9 qtrs — |
| 20 | GOLDMAN SACHS GROUP INC | 787.3K +20.7K (+2.7%) | 16.84M +4.0M (+31.2%) | 0.92% +0.040 pp | 0.00% +0.001 pp | USD12.69 +68.6% | 68 qtrs — |
| 21 | BRIDGEWAY CAPITAL MANAGEMENT, LLC | 740.3K +93.5K (+14.5%) | 15.83M +5.0M (+46.2%) | 0.87% +0.123 pp | 0.33% +0.101 pp | USD11.82 +81.0% | 9 qtrs — |
| 22 | QUBE RESEARCH & TECHNOLOGIES LTD | 727.3K -416.0K (-36.4%) | 15.56M -3.6M (-18.8%) | 0.85% -0.464 pp | 0.02% -0.004 pp | USD13.17 +62.4% | 12 qtrs — |
| 23 | JPMORGAN CHASE & CO | 710.7K -116.4K (-14.1%) | 15.20M +1.3M (+9.7%) | 0.83% -0.120 pp | 0.00% +0.000 pp | USD11.90 +79.7% | 51 qtrs — |
| 24 | AMERIPRISE FINANCIAL INC | 670.7K -1.0K (-0.1%) | 14.35M +3.1M (+27.5%) | 0.79% +0.012 pp | 0.00% +0.001 pp | USD19.24 +11.2% | 51 qtrs — |
| 25 | DANA INVESTMENT ADVISORS, INC. | 648.7K -152.7K (-19.1%) | 13.88M +451.7K (+3.4%) | 0.76% -0.163 pp | 0.40% +0.011 pp | USD9.00 +137.7% | 8 qtrs — |
| 26 | ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC | 639.4K +639.4K (+100.0%) | 13.61M +13.6M (+100.0%) | 0.75% +0.749 pp | 0.02% +0.022 pp | USD21.39 +0.0% | 1 qtrs NEW |
| 27 | EMPOWERED FUNDS, LLC | 622.4K +93.8K (+17.8%) | 13.31M +4.5M (+50.4%) | 0.73% +0.121 pp | 0.11% +0.016 pp | USD13.39 +59.7% | 9 qtrs — |
| 28 | ROCKEFELLER CAPITAL MANAGEMENT L.P. | 594.4K +529.4K (+814.6%) | 12.71M +11.6M (+1,068.0%) | 0.70% +0.621 pp | 0.02% +0.021 pp | USD20.88 +2.4% | 2 qtrs — |
| 29 | BANK OF NEW YORK MELLON CORP | 587.1K -14.7K (-2.5%) | 12.56M +2.5M (+24.6%) | 0.69% -0.005 pp | 0.00% +0.000 pp | USD41.64 -48.6% | 66 qtrs — |
| 30 | UBS GROUP AG | 585.8K +276.6K (+89.5%) | 12.53M +7.4M (+142.0%) | 0.69% +0.330 pp | 0.00% +0.001 pp | USD17.16 +24.7% | 45 qtrs — |
| 31 | ARROWMARK COLORADO HOLDINGS LLC | 566.3K -40.2K (-6.6%) | 12.11M +2.0M (+19.2%) | 0.66% -0.035 pp | 0.27% +0.078 pp | USD20.22 +5.8% | 38 qtrs — |
| 32 | OBERWEIS ASSET MANAGEMENT INC/ | 560.0K +14.4K (+2.6%) | 11.98M +2.8M (+31.1%) | 0.66% +0.028 pp | 0.44% +0.088 pp | USD13.53 +58.1% | 5 qtrs — |
| 33 | AQR CAPITAL MANAGEMENT LLC | 551.8K +24.6K (+4.7%) | 11.80M +3.1M (+36.4%) | 0.65% +0.039 pp | 0.01% +0.001 pp | USD13.99 +52.9% | 17 qtrs — |
| 34 | BANK OF AMERICA CORP /DE/ | 529.6K -14.4K (-2.7%) | 11.33M +2.2M (+24.3%) | 0.62% -0.006 pp | 0.00% +0.000 pp | USD13.66 +56.6% | 52 qtrs — |
| 35 | PANAGORA ASSET MANAGEMENT INC | 520.1K +16.5K (+3.3%) | 11.13M +2.7M (+31.9%) | 0.61% +0.030 pp | 0.04% +0.005 pp | USD13.13 +62.9% | 6 qtrs — |
| 36 | PACER ADVISORS, INC. | 494.4K -116.5K (-19.1%) | 10.57M +342.1K (+3.3%) | 0.58% -0.124 pp | 0.03% +0.001 pp | USD13.12 +63.0% | 5 qtrs — |
| 37 | PRINCIPAL FINANCIAL GROUP INC | 474.5K +13.7K (+3.0%) | 10.15M +2.4M (+31.5%) | 0.56% +0.025 pp | 0.01% +0.001 pp | USD28.23 -24.2% | 68 qtrs — |
| 38 | LSV ASSET MANAGEMENT | 462.2K +156.4K (+51.1%) | 9.89M +4.8M (+93.0%) | 0.54% +0.189 pp | 0.02% +0.010 pp | USD16.66 +28.4% | 12 qtrs — |
| 39 | HILLSDALE INVESTMENT MANAGEMENT INC. | 450.4K -1.8K (-0.4%) | 9.63M +2.1M (+27.2%) | 0.53% +0.007 pp | 0.27% +0.037 pp | USD14.75 +45.0% | 5 qtrs — |
| 40 | BRANDES INVESTMENT PARTNERS, LP | 442.3K -188.4K (-29.9%) | 9.46M -1.1M (-10.5%) | 0.52% -0.208 pp | 0.07% -0.013 pp | USD13.65 +56.7% | 33 qtrs — |
| 41 | ARISTOTLE CAPITAL BOSTON, LLC | 440.1K -43.9K (-9.1%) | 9.41M +1.3M (+16.1%) | 0.52% -0.042 pp | 0.52% +0.099 pp | USD30.45 -29.8% | 45 qtrs — |
| 42 | CASTLEKNIGHT MANAGEMENT LP | 396.1K -285.9K (-41.9%) | 8.47M -3.0M (-25.8%) | 0.46% -0.321 pp | 0.19% -0.037 pp | USD11.04 +93.8% | 7 qtrs — |
| 43 | PUBLIC SECTOR PENSION INVESTMENT BOARD | 386.1K -23.6K (-5.7%) | 8.26M +1.4M (+20.4%) | 0.45% -0.019 pp | 0.03% +0.003 pp | USD16.44 +30.1% | 21 qtrs — |
| 44 | BRANDYWINE GLOBAL INVESTMENT MANAGEMENT, LLC | 344.0K -12.8K (-3.6%) | 7.36M +1.4M (+23.1%) | 0.40% -0.008 pp | 0.05% +0.008 pp | USD14.35 +49.1% | 3 qtrs — |
| 45 | PHOCAS FINANCIAL CORP. | 335.6K +103.3K (+44.5%) | 7.18M +3.3M (+84.5%) | 0.39% +0.126 pp | 0.93% +0.429 pp | USD18.18 +17.7% | 2 qtrs — |
| 46 | CSM ADVISORS, LLC | 330.2K +16.5K (+5.3%) | 7.06M +1.8M (+34.5%) | 0.39% +0.026 pp | 0.19% +0.045 pp | USD15.51 +37.9% | 3 qtrs — |
| 47 | TEACHER RETIREMENT SYSTEM OF TEXAS | 306.7K +62.4K (+25.6%) | 6.56M +2.5M (+60.3%) | 0.36% +0.078 pp | 0.02% +0.006 pp | USD16.20 +32.0% | 5 qtrs — |
| 48 | ENVESTNET ASSET MANAGEMENT INC | 286.2K +273.5K (+2,153.9%) | 6.12M +5.9M (+2,778.2%) | 0.34% +0.321 pp | 0.00% +0.002 pp | USD21.18 +1.0% | 2 qtrs — |
| 49 | PRUDENTIAL FINANCIAL INC | 279.9K -43.9K (-13.6%) | 5.99M +563.7K (+10.4%) | 0.33% -0.045 pp | 0.01% +0.001 pp | USD12.50 +71.1% | 68 qtrs — |
| 50 | RAYMOND JAMES FINANCIAL INC | 274.9K +27.5K (+11.1%) | 5.88M +1.7M (+41.9%) | 0.32% +0.037 pp | 0.00% +0.001 pp | USD14.01 +52.7% | 5 qtrs — |
| 51 | ALLIANZ ASSET MANAGEMENT GMBH | 265.3K +106.6K (+67.1%) | 5.68M +3.0M (+113.4%) | 0.31% +0.128 pp | 0.01% +0.003 pp | USD17.81 +20.1% | 18 qtrs — |
| 52 | ROYCE & ASSOCIATES LP | 254.7K +75.7K (+42.3%) | 5.45M +2.5M (+81.7%) | 0.30% +0.092 pp | 0.06% +0.025 pp | USD14.33 +49.3% | 11 qtrs — |
| 53 | DZ BANK AG DEUTSCHE ZENTRAL GENOSSENSCHAFTS BANK, FRANKFURT AM MAIN | 250.0K -43.6K (-14.9%) | 5.35M +429.2K (+8.7%) | 0.29% -0.045 pp | 0.00% +0.000 pp | USD14.35 +49.1% | 3 qtrs — |
| 54 | LORD, ABBETT & CO. LLC | 247.7K +247.7K (+100.0%) | 5.30M +5.3M (+100.0%) | 0.29% +0.290 pp | 0.02% +0.016 pp | USD21.39 +0.0% | 1 qtrs NEW |
| 55 | NORDEA INVESTMENT MANAGEMENT AB | 239.9K -34.9K (-12.7%) | 5.18M +687.8K (+15.3%) | 0.28% -0.035 pp | 0.00% +0.001 pp | USD21.00 +1.9% | 58 qtrs — |
| 56 | UBS ASSET MANAGEMENT AMERICAS INC | 240.0K +1.7K (+0.7%) | 5.13M +1.1M (+28.6%) | 0.28% +0.007 pp | 0.00% +0.000 pp | USD12.25 +74.6% | 68 qtrs — |
| 57 | LEGAL & GENERAL GROUP PLC | 215.4K -15.6K (-6.8%) | 4.61M +737.8K (+19.1%) | 0.25% -0.014 pp | 0.00% +0.000 pp | USD33.86 -36.8% | 60 qtrs — |
| 58 | O'SHAUGHNESSY ASSET MANAGEMENT, LLC | 198.3K +183.1K (+1,203.5%) | 4.24M +4.0M (+1,564.5%) | 0.23% +0.215 pp | 0.02% +0.022 pp | USD20.80 +2.8% | 5 qtrs — |
| 59 | SEI INVESTMENTS CO | 195.0K +12.1K (+6.6%) | 4.17M +1.1M (+36.1%) | 0.23% +0.018 pp | 0.00% +0.001 pp | USD26.52 -19.3% | 45 qtrs — |
| 60 | ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 192.5K +23.2K (+13.7%) | 4.12M +1.3M (+45.2%) | 0.23% +0.031 pp | 0.00% +0.001 pp | USD15.20 +40.7% | 3 qtrs — |
| 61 | RHUMBLINE ADVISERS | 186.1K -30.3K (-14.0%) | 3.98M +356.4K (+9.8%) | 0.22% -0.031 pp | 0.00% +0.000 pp | USD30.92 -30.8% | 51 qtrs — |
| 62 | EAM INVESTORS, LLC | 182.7K +182.7K (+100.0%) | 3.91M +3.9M (+100.0%) | 0.21% +0.214 pp | 0.44% +0.435 pp | USD21.39 +0.0% | 1 qtrs NEW |
| 63 | RUSSELL INVESTMENTS GROUP, LTD. | 177.7K +25.8K (+17.0%) | 3.80M +1.3M (+49.4%) | 0.21% +0.033 pp | 0.00% +0.001 pp | USD14.88 +43.8% | 37 qtrs — |
| 64 | TREXQUANT INVESTMENT LP | 174.2K -37.1K (-17.6%) | 3.73M +186.3K (+5.3%) | 0.20% -0.039 pp | 0.03% -0.003 pp | USD16.75 +27.7% | 10 qtrs — |
| 65 | SWISS NATIONAL BANK | 171.8K +5.3K (+3.2%) | 3.67M +885.9K (+31.8%) | 0.20% +0.010 pp | 0.00% +0.001 pp | USD45.09 -52.6% | 51 qtrs — |
| 66 | MARTINGALE ASSET MANAGEMENT L P | 169.6K -8.6K (-4.8%) | 3.63M +643.4K (+21.6%) | 0.20% -0.007 pp | 0.09% +0.017 pp | USD13.50 +58.4% | 12 qtrs — |
| 67 | CASTLEARK MANAGEMENT LLC | 159.1K +159.1K (+100.0%) | 3.40M +3.4M (+100.0%) | 0.19% +0.186 pp | 0.10% +0.100 pp | USD21.39 +0.0% | 1 qtrs NEW |
| 68 | BARCLAYS PLC | 158.5K +16.5K (+11.6%) | 3.39M +1.7M (+105.9%) | 0.19% +0.022 pp | 0.00% +0.000 pp | USD13.77 +55.3% | 51 qtrs — |
| 69 | BRIDGE CITY CAPITAL, LLC | 149.9K -87.0K (-36.7%) | 3.21M -761.2K (-19.2%) | 0.18% -0.097 pp | 0.94% -0.117 pp | USD19.53 +9.5% | 34 qtrs — |
| 70 | BESSEMER GROUP INC | 147.2K +146.1K (+13,365.3%) | 3.15M +3.1M (+16,468.4%) | 0.17% +0.171 pp | 0.00% +0.005 pp | USD21.32 +0.3% | 8 qtrs — |
| 71 | FIRST TRUST ADVISORS LP | 146.1K +146.1K (+100.0%) | 3.13M +3.1M (+100.0%) | 0.17% +0.171 pp | 0.00% +0.002 pp | USD21.39 +0.0% | 1 qtrs NEW |
| 72 | BNP PARIBAS ARBITRAGE, SNC | 143.9K -327.8K (-69.5%) | 3.08M -4.8M (-61.0%) | 0.17% -0.375 pp | 0.00% -0.003 pp | USD14.26 +50.0% | 49 qtrs — |
| 73 | SEGALL BRYANT & HAMILL, LLC | 142.9K -769.0 (-0.5%) | 3.06M +650.4K (+27.0%) | 0.17% +0.002 pp | 0.04% +0.009 pp | USD15.17 +41.0% | 25 qtrs — |
| 74 | LAZARD ASSET MANAGEMENT LLC | 138.4K +35.3K (+34.3%) | 2.96M +1.2M (+71.5%) | 0.16% +0.044 pp | 0.01% +0.003 pp | USD16.39 +30.5% | 5 qtrs — |
| 75 | NEW YORK STATE TEACHERS RETIREMENT SYSTEM | 134.8K -6.8K (-4.8%) | 2.88M +511.0K (+21.6%) | 0.16% -0.005 pp | 0.01% +0.001 pp | USD37.55 -43.0% | 51 qtrs — |
| 76 | CLARK ESTATES INC/NY | 129.0K -42.3K (-24.7%) | 2.76M -110.2K (-3.8%) | 0.15% -0.046 pp | 0.67% +0.014 pp | USD9.30 +130.0% | 9 qtrs — |
| 77 | ENGINEERS GATE MANAGER LP | 125.1K -25.7K (-17.0%) | 2.68M +149.9K (+5.9%) | 0.15% -0.027 pp | 0.03% +0.003 pp | USD13.40 +59.6% | 28 qtrs — |
| 78 | WEDGE CAPITAL MANAGEMENT L L P/NC | 124.1K -14.2K (-10.3%) | 2.65M +338.1K (+14.6%) | 0.15% -0.014 pp | 0.05% +0.008 pp | USD16.75 +27.7% | 2 qtrs — |
| 79 | WELLS FARGO & COMPANY/MN | 120.2K +41.1K (+52.0%) | 2.57M +1.2M (+94.1%) | 0.14% +0.050 pp | 0.00% +0.000 pp | USD22.60 -5.4% | 57 qtrs — |
| 80 | RBF CAPITAL, LLC | 120.0K -10.0K (-7.7%) | 2.57M +389.3K (+17.9%) | 0.14% -0.009 pp | 0.11% +0.017 pp | USD11.59 +84.6% | 6 qtrs — |
| 81 | BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. | 119.2K +118.2K (+11,770.0%) | 2.55M +2.5M (+14,894.1%) | 0.14% +0.138 pp | 0.00% +0.003 pp | USD21.33 +0.3% | 3 qtrs — |
| 82 | HSBC HOLDINGS PLC | 115.7K -16.5K (-12.5%) | 2.49M +302.2K (+13.8%) | 0.14% -0.017 pp | 0.00% +0.000 pp | USD13.88 +54.1% | 9 qtrs — |
| 83 | GREAT LAKES ADVISORS, LLC | 115.7K -52.4K (-31.2%) | 2.47M -341.3K (-12.1%) | 0.14% -0.058 pp | 0.02% -0.003 pp | USD14.35 +49.1% | 3 qtrs — |
| 84 | NEW YORK STATE COMMON RETIREMENT FUND | 115.2K -1.7K (-1.5%) | 2.46M +506.0K (+25.8%) | 0.14% +0.000 pp | 0.00% +0.001 pp | USD20.55 +4.1% | 68 qtrs — |
| 85 | GOTHAM ASSET MANAGEMENT, LLC | 112.9K -3.2K (-2.8%) | 2.41M +469.4K (+24.1%) | 0.13% -0.002 pp | 0.01% +0.000 pp | USD13.29 +60.9% | 12 qtrs — |
| 86 | JANE STREET GROUP, LLC | 110.8K -110.8K (-50.0%) | 2.37M -1.3M (-36.2%) | 0.13% -0.125 pp | 0.00% 0.000 pp | USD10.96 +95.2% | 29 qtrs — |
| 87 | CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 108.5K -109.9K (-50.3%) | 2.32M -1.3M (-36.5%) | 0.13% -0.124 pp | 0.01% -0.005 pp | USD14.24 +50.2% | 14 qtrs — |
| 88 | JACKSON CREEK INVESTMENT ADVISORS LLC | 105.9K -4.2K (-3.9%) | 2.27M +420.0K (+22.8%) | 0.12% -0.003 pp | 0.67% +0.135 pp | USD14.35 +49.1% | 3 qtrs — |
| 89 | RITHOLTZ WEALTH MANAGEMENT | 101.1K +101.1K (+100.0%) | 2.16M +2.2M (+100.0%) | 0.12% +0.118 pp | 0.04% +0.040 pp | USD21.39 +0.0% | 5 qtrs — |
| 90 | XTX TOPCO LTD | 99.9K +82.8K (+483.4%) | 2.14M +1.8M (+645.1%) | 0.12% +0.097 pp | 0.06% +0.041 pp | USD20.15 +6.2% | 5 qtrs — |
| 91 | NOMURA HOLDINGS INC | 97.6K -66.9K (-40.6%) | 2.09M -666.8K (-24.2%) | 0.11% -0.075 pp | 0.00% -0.002 pp | USD13.79 +55.1% | 5 qtrs — |
| 92 | PRICE T ROWE ASSOCIATES INC /MD/ | 86.6K +3.8K (+4.6%) | 1.85M +465.0K (+33.5%) | 0.10% +0.006 pp | 0.00% +0.000 pp | USD24.73 -13.5% | 68 qtrs — |
| 93 | ZACKS INVESTMENT MANAGEMENT | 83.8K -5.9K (-6.6%) | 1.79M +289.9K (+19.3%) | 0.10% -0.005 pp | 0.01% +0.002 pp | USD16.75 +27.7% | 2 qtrs — |
| 94 | ROYAL BANK OF CANADA | 83.0K +74.9K (+921.3%) | 1.78M +1.6M (+1,195.6%) | 0.10% +0.088 pp | 0.00% +0.000 pp | USD20.57 +4.0% | 51 qtrs — |
| 95 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 82.6K +3.3K (+4.1%) | 1.77M +438.4K (+33.0%) | 0.10% +0.005 pp | 0.00% +0.000 pp | USD42.01 -49.1% | 52 qtrs — |
| 96 | INTEGRATED QUANTITATIVE INVESTMENTS LLC | 79.6K +5.5K (+7.4%) | 1.70M +461.0K (+37.2%) | 0.09% +0.008 pp | 0.37% +0.013 pp | USD14.97 +42.9% | 4 qtrs — |
| 97 | CITADEL ADVISORS LLC | 78.1K -14.4K (-15.6%) | 1.67M +121.1K (+7.8%) | 0.09% -0.015 pp | 0.00% +0.000 pp | USD12.65 +69.1% | 18 qtrs — |
| 98 | EXCHANGE TRADED CONCEPTS, LLC | 77.1K +6.3K (+8.9%) | 1.65M +462.9K (+39.0%) | 0.09% +0.009 pp | 0.01% +0.003 pp | USD17.13 +24.9% | 2 qtrs — |
| 99 | MILLENNIUM MANAGEMENT LLC | 76.1K -88.0K (-53.6%) | 1.63M -1.1M (-40.8%) | 0.09% -0.100 pp | 0.00% -0.001 pp | USD13.69 +56.2% | 19 qtrs — |
| 100 | FRANKLIN RESOURCES INC | 75.5K +4.6K (+6.6%) | 1.62M +428.2K (+36.1%) | 0.09% +0.007 pp | 0.00% +0.000 pp | USD13.23 +61.7% | 6 qtrs — |
Insider Activity
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-01 | Rossi Kasandra H | Officer | F-InKind | D | Common Stock | 3,676 | 19.85 | 73.0K | 73,300 | D | ↗ |
| 2026-03-01 | Moore Mary Ann E | Officer | A-Award | A | Common Stock | 39,925 | 0.00 | — | 176,167 | D | ↗ |
| 2025-12-15 | ORDAN MARK S | Director / Officer | S-Sale | D | Common Stock | 23,000 | 22.41 | 515.4K | 302,805 | D | ↗ |
| 2025-11-17 | Rucker Michael A. | Director | S-Sale | D | Common Stock | 10,478 | 23.00 | 241.0K | 59,101 | D | ↗ |
| 2025-11-06 | Linynsky Laura A | Director | S-Sale | D | Common Stock | 10,000 | 21.65 | 216.5K | 32,232 | D | ↗ |
| 2025-08-20 | McEachin Thomas | Director | G-Gift | D | Common Stock | 625 | 0.00 | — | 11,427 | D | ↗ |
| 2025-08-19 | McEachin Thomas | Director | G-Gift | D | Common Stock | 54,021 | 0.00 | — | 12,052 | D | ↗ |
| 2025-08-01 | Newman Kurt Douglas | Director | A-Award | A | Common Stock | 9,737 | 0.00 | — | 9,737 | D | ↗ |
| 2025-08-01 | Neeb Don Gregory | Officer | A-Award | A | Common Stock | 81,346 | 0.00 | — | 81,346 | D | ↗ |
| 2025-07-01 | Newman Kurt Douglas | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2025-06-10 | Moore Mary Ann E | Officer | G-Gift | D | Common Stock | 10,371 | 0.00 | — | 136,242 | D | ↗ |
| 2025-06-01 | Rossi Kasandra H | Officer | A-Award | A | Common Stock | 26,502 | 0.00 | — | 77,653 | D | ↗ |
| 2025-06-01 | ORDAN MARK S | Director / Officer | A-Award | A | Common Stock | 194,347 | 0.00 | — | 325,805 | D | ↗ |
| 2025-06-01 | Moore Mary Ann E | Officer | A-Award | A | Common Stock | 53,004 | 0.00 | — | 153,342 | D | ↗ |
| 2025-05-23 | Weis Shirley A | Director | G-Gift | D | Common Stock | 18,360 | 0.00 | — | 11,427 | D | ↗ |
| 2025-05-09 | ORDAN MARK S | Director / Officer | F-InKind | D | Common Stock | 7,225 | 14.44 | 104.3K | 131,458 | D | ↗ |
| 2025-05-08 | Young Sylvia Jean | Director | A-Award | A | Common Stock | 11,427 | 0.00 | — | 40,618 | D | ↗ |
| 2025-05-08 | Weis Shirley A | Director | A-Award | A | Common Stock | 11,427 | 0.00 | — | 29,787 | D | ↗ |
| 2025-05-08 | Starcher John M. Jr. | Director | A-Award | A | Common Stock | 11,427 | 0.00 | — | 66,064 | D | ↗ |
| 2025-05-08 | SANSONE GUY P | Director | A-Award | A | Common Stock | 11,427 | 0.00 | — | 79,748 | D | ↗ |
| 2025-05-08 | Rucker Michael A. | Director | A-Award | A | Common Stock | 11,427 | 0.00 | — | 69,579 | D | ↗ |
| 2025-05-08 | McEachin Thomas | Director | A-Award | A | Common Stock | 11,427 | 0.00 | — | 66,073 | D | ↗ |
| 2025-05-08 | Linynsky Laura A | Director | A-Award | A | Common Stock | 11,427 | 0.00 | — | 42,232 | D | ↗ |
| 2025-03-06 | Moore Mary Ann E | Officer | G-Gift | D | Common Stock | 26,497 | 0.00 | — | 100,338 | D | ↗ |
| 2025-03-01 | Rossi Kasandra H | Officer | F-InKind | D | Common Stock | 3,718 | 14.77 | 54.9K | 51,151 | D | ↗ |
| 2025-03-01 | Moore Mary Ann E | Officer | F-InKind | D | Common Stock | 8,975 | 14.77 | 132.6K | 126,835 | D | ↗ |
| 2025-02-25 | Weis Shirley A | Director | G-Gift | D | Common Stock | 17,668 | 0.00 | — | 18,360 | D | ↗ |
| 2025-01-12 | ORDAN MARK S | Director / Officer | A-Award | A | Performance Share Unit | 640,000 | 0.00 | — | 640,000 | D | ↗ |
| 2024-12-01 | Rossi Kasandra H | Officer | A-Award | A | Common Stock | 11,112 | 0.00 | — | 54,869 | D | ↗ |
| 2024-11-13 | ORDAN MARK S | Director | S-Sale | D | Common Stock | 27,600 | 15.35 | 423.7K | 138,683 | D | ↗ |
| 2024-11-08 | Moore Mary Ann E | Officer | S-Sale | D | Common Stock | 8,108 | 16.00 | 129.7K | 135,810 | D | ↗ |
| 2024-10-01 | Rossi Kasandra H | Officer | — | — | Common Stock | 0 | 0.00 | — | 43,757 | D | ↗ |
| 2024-08-30 | Swift James D | Director / Officer | S-Sale | D | Common Stock | 11,100 | 10.79 | 119.8K | 170,001 | — | ↗ |
| 2024-08-27 | Linynsky Laura A | Director | S-Sale | D | Common Stock | 7,000 | 11.16 | 78.1K | 30,805 | — | ↗ |
| 2024-08-12 | Richards C Marc | Officer | S-Sale | D | Common Stock | 17,438 | 10.08 | 175.8K | 175,347 | — | ↗ |
| 2024-08-09 | Richards C Marc | Officer | S-Sale | D | Common Stock | 32,562 | 10.08 | 328.2K | 192,785 | — | ↗ |
| 2024-06-01 | Wood Lee | Officer | A-Award | A | Common Stock | 51,300 | 0.00 | — | 118,094 | — | ↗ |
| 2024-06-01 | Swift James D | Director / Officer | A-Award | A | Common Stock | 105,165 | 0.00 | — | 181,101 | — | ↗ |
| 2024-06-01 | Richards C Marc | Officer | A-Award | A | Common Stock | 95,760 | 0.00 | — | 225,347 | — | ↗ |
| 2024-06-01 | Pickert Curtis | Officer | A-Award | A | Common Stock | 68,400 | 0.00 | — | 121,401 | — | ↗ |
| 2024-06-01 | Moore Mary Ann E | Officer | A-Award | A | Common Stock | 68,400 | 0.00 | — | 143,918 | — | ↗ |
| 2024-05-09 | Young Sylvia Jean | Director | A-Award | A | Common Stock | 18,360 | 0.00 | — | 29,191 | — | ↗ |
| 2024-05-09 | Weis Shirley A | Director | A-Award | A | Common Stock | 18,360 | 0.00 | — | 36,028 | — | ↗ |
| 2024-05-09 | Starcher John M. Jr. | Director | A-Award | A | Common Stock | 18,360 | 0.00 | — | 54,637 | — | ↗ |
| 2024-05-09 | SANSONE GUY P | Director | A-Award | A | Common Stock | 18,360 | 0.00 | — | 68,321 | — | ↗ |
| 2024-05-09 | Rucker Michael A. | Director | A-Award | A | Common Stock | 18,360 | 0.00 | — | 58,152 | — | ↗ |
| 2024-05-09 | ORDAN MARK S | Director | A-Award | A | Common Stock | 18,360 | 0.00 | — | 166,283 | — | ↗ |
| 2024-05-09 | McEachin Thomas | Director | A-Award | A | Common Stock | 18,360 | 0.00 | — | 54,646 | — | ↗ |
| 2024-05-09 | Linynsky Laura A | Director | A-Award | A | Common Stock | 18,360 | 0.00 | — | 37,805 | — | ↗ |
| 2024-03-13 | Pickert Curtis | Officer | G-Gift | D | Common Stock | 12,923 | 0.00 | — | 53,001 | — | ↗ |
| 2024-03-01 | Wood Lee | Officer | F-InKind | D | Common Stock | 4,962 | 9.15 | 45.4K | 66,794 | — | ↗ |
| 2024-03-01 | Swift James D | Director / Officer | F-InKind | D | Common Stock | 14,938 | 9.15 | 136.7K | 75,936 | — | ↗ |
| 2024-03-01 | Richards C Marc | Officer | F-InKind | D | Common Stock | 21,428 | 9.15 | 196.1K | 129,587 | — | ↗ |
| 2024-03-01 | Pickert Curtis | Officer | F-InKind | D | Common Stock | 9,160 | 9.15 | 83.8K | 65,924 | — | ↗ |
| 2024-03-01 | Moore Mary Ann E | Officer | F-InKind | D | Common Stock | 5,867 | 9.15 | 53.7K | 75,518 | — | ↗ |
| 2023-12-14 | Swift James D | Director / Officer | S-Sale | D | Common Stock | 5,764 | 9.58 | 55.2K | 90,874 | — | ↗ |
| 2023-12-14 | Moore Mary Ann E | Officer | S-Sale | D | Common Stock | 970 | 9.62 | 9.3K | 81,385 | — | ↗ |
| 2023-06-14 | Swift James D | Director / Officer | S-Sale | D | Common Stock | 13,193 | 14.14 | 186.5K | 96,638 | — | ↗ |
| 2023-06-07 | Pickert Curtis | Officer | G-Gift | D | Common Stock | 1,166 | 0.00 | — | 75,084 | — | ↗ |
| 2023-06-01 | Wood Lee | Officer | F-InKind | D | Common Stock | 407 | 13.30 | 5.4K | 71,756 | — | ↗ |
| 2023-06-01 | Pickert Curtis | Officer | F-InKind | D | Common Stock | 376 | 13.30 | 5.0K | 76,250 | — | ↗ |
| 2023-05-25 | ORDAN MARK S | Director | S-Sale | D | Common Stock | 33,000 | 13.26 | 437.6K | 147,923 | — | ↗ |
| 2023-05-19 | Weis Shirley A | Director | S-Sale | D | Common Stock | 1,007 | 13.63 | 13.7K | 17,668 | — | ↗ |
| 2023-05-18 | Weis Shirley A | Director | S-Sale | D | Common Stock | 17,993 | 13.55 | 243.8K | 18,675 | — | ↗ |
| 2023-05-15 | Pickert Curtis | Officer | G-Gift | D | Common Stock | 5,984 | 0.00 | — | 76,626 | — | ↗ |
| 2023-05-12 | Young Sylvia Jean | Director | A-Award | A | Common Stock | 10,831 | 0.00 | — | 10,831 | — | ↗ |
| 2023-05-11 | Weis Shirley A | Director | A-Award | A | Common Stock | 10,965 | 0.00 | — | 36,668 | — | ↗ |
| 2023-05-11 | Starcher John M. Jr. | Director | A-Award | A | Common Stock | 10,965 | 0.00 | — | 36,277 | — | ↗ |
| 2023-05-11 | SANSONE GUY P | Director | A-Award | A | Common Stock | 10,965 | 0.00 | — | 49,961 | — | ↗ |
| 2023-05-11 | Rucker Michael A. | Director | A-Award | A | Common Stock | 10,965 | 0.00 | — | 39,792 | — | ↗ |
| 2023-05-11 | ORDAN MARK S | Director | A-Award | A | Common Stock | 9,463 | 0.00 | — | 180,923 | — | ↗ |
| 2023-05-11 | McEachin Thomas | Director | A-Award | A | Common Stock | 10,965 | 0.00 | — | 36,286 | — | ↗ |
| 2023-05-11 | Linynsky Laura A | Director | A-Award | A | Common Stock | 10,965 | 0.00 | — | 19,445 | — | ↗ |
| 2023-03-01 | Wood Lee | Officer | A-Award | A | Common Stock | 39,806 | 0.00 | — | 74,207 | — | ↗ |
| 2023-03-01 | Swift James D | Officer | A-Award | A | Common Stock | 49,758 | 0.00 | — | 119,740 | — | ↗ |
| 2023-03-01 | Richards C Marc | Officer | F-InKind | D | Common Stock | 9,991 | 15.74 | 157.3K | 151,015 | — | ↗ |
| 2023-03-01 | Pickert Curtis | Officer | F-InKind | D | Common Stock | 2,300 | 15.74 | 36.2K | 82,610 | — | ↗ |
| 2023-03-01 | Moore Mary Ann E | Officer | A-Award | A | Common Stock | 55,664 | 0.00 | — | 84,700 | — | ↗ |
| 2023-02-13 | Wood Lee | Officer | — | D | Common Stock | 0 | 0.00 | — | 34,401 | — | ↗ |
| 2023-02-13 | Pickert Curtis | Officer | — | D | Common Stock | 0 | 0.00 | — | 29,246 | — | ↗ |
| 2022-12-31 | ORDAN MARK S | Officer | F-InKind | D | Common Stock | 98,932 | 14.86 | 1.47M | 247,713 | — | ↗ |
| 2022-11-21 | ORDAN MARK S | Officer | S-Sale | D | Common Stock | 22,166 | 15.45 | 342.5K | 346,645 | — | ↗ |
| 2022-11-07 | Swift James D | Officer | S-Sale | D | Common Stock | 24,000 | 15.31 | 367.4K | 87,956 | — | ↗ |
| 2022-09-26 | Andreano Dominic J | Officer | F-InKind | D | Common Stock | 4,267 | 16.81 | 71.7K | 189,440 | — | ↗ |
| 2022-05-12 | Weis Shirley A | Director | A-Award | A | Common Stock | 8,480 | 0.00 | — | 25,703 | — | ↗ |
| 2022-05-12 | Starcher John M. Jr. | Director | A-Award | A | Common Stock | 8,480 | 0.00 | — | 25,312 | — | ↗ |
| 2022-05-12 | SANSONE GUY P | Director | A-Award | A | Common Stock | 8,480 | 0.00 | — | 38,996 | — | ↗ |
| 2022-05-12 | Rucker Michael A. | Director | A-Award | A | Common Stock | 8,480 | 0.00 | — | 28,827 | — | ↗ |
| 2022-05-12 | McEachin Thomas | Director | A-Award | A | Common Stock | 8,480 | 0.00 | — | 25,321 | — | ↗ |
| 2022-05-12 | MEDEL ROGER MD | Director | A-Award | A | Common Stock | 8,480 | 0.00 | — | 747,930 | — | ↗ |
| 2022-05-12 | Linynsky Laura A | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2022-03-01 | Richards C Marc | Officer | F-InKind | D | Common Stock | 6,874 | 23.47 | 161.3K | 146,199 | — | ↗ |
| 2022-03-01 | ORDAN MARK S | Director / Officer | A-Award | A | Common Stock | 76,253 | 0.00 | — | 313,249 | — | ↗ |
| 2022-03-01 | Moore Mary Ann E | Officer | A-Award | A | Common Stock | 16,340 | 0.00 | — | 30,561 | — | ↗ |
| 2022-03-01 | Hinson Roger Mack | Officer | F-InKind | D | Common Stock | 10,244 | 23.47 | 240.4K | 109,457 | — | ↗ |
| 2022-03-01 | Andreano Dominic J | Officer | A-Award | A | Common Stock | 29,412 | 0.00 | — | 170,930 | — | ↗ |
| 2022-01-11 | MEDEL ROGER MD | Director | S-Sale | D | Common Stock | 40,107 | 26.58 | 1.07M | 739,450 | — | ↗ |
| 2022-01-10 | MEDEL ROGER MD | Director | S-Sale | D | Common Stock | 59,893 | 26.44 | 1.58M | 779,557 | — | ↗ |
| 2022-01-05 | MEDEL ROGER MD | Director | S-Sale | D | Common Stock | 12,639 | 27.42 | 346.6K | 839,450 | — | ↗ |
| 2022-01-04 | MEDEL ROGER MD | Director | S-Sale | D | Common Stock | 87,361 | 27.43 | 2.40M | 852,089 | — | ↗ |
| 2021-12-31 | MEDEL ROGER MD | Director | S-Sale | D | Common Stock | 6,564 | 27.16 | 178.3K | 939,450 | — | ↗ |
| 2021-12-30 | MEDEL ROGER MD | Director | S-Sale | D | Common Stock | 45,397 | 27.19 | 1.23M | 946,014 | — | ↗ |
| 2021-12-29 | MEDEL ROGER MD | Director | S-Sale | D | Common Stock | 25,000 | 27.28 | 682.0K | 991,411 | — | ↗ |
| 2021-12-28 | MEDEL ROGER MD | Director | S-Sale | D | Common Stock | 44,514 | 27.28 | 1.21M | 1,016,411 | — | ↗ |
| 2021-12-27 | MEDEL ROGER MD | Director | S-Sale | D | Common Stock | 66,868 | 27.17 | 1.82M | 1,060,925 | — | ↗ |
| 2021-11-16 | Moore Mary Ann E | Officer | — | I | Common Stock | 0 | 0.00 | — | 16,880 | — | ↗ |
| 2021-11-10 | Pepia John C | Officer | S-Sale | D | Common Stock | 5,000 | 28.45 | 142.3K | 96,666 | — | ↗ |
| 2021-11-10 | Hinson Roger Mack | Officer | S-Sale | D | Common Stock | 8,800 | 28.38 | 249.7K | 107,391 | — | ↗ |
| 2021-10-29 | Pepia John C | Officer | S-Sale | D | Common Stock | 9,238 | 26.87 | 248.2K | 101,666 | — | ↗ |
| 2021-10-28 | MEDEL ROGER MD | Director | S-Sale | D | Common Stock | 10,387 | 29.00 | 301.2K | 1,127,793 | — | ↗ |
| 2021-10-04 | MEDEL ROGER MD | Director | S-Sale | D | Common Stock | 1,270 | 29.00 | 36.8K | 1,138,180 | — | ↗ |
| 2021-09-26 | Richards C Marc | Officer | — | D | Employee Stock Options (right to buy) | 192,400 | 16.14 | 3.11M | 0 | — | ↗ |
| 2021-09-26 | Hinson Roger Mack | Officer | — | D | Employee Stock Option (right to buy) | 144,000 | 16.14 | 2.32M | 0 | — | ↗ |
| 2021-09-02 | Pepia John C | Officer | S-Sale | D | Common Stock | 10,000 | 31.83 | 318.3K | 110,843 | — | ↗ |
| 2021-08-30 | ORDAN MARK S | Director / Officer | S-Sale | D | Common Stock | 95,000 | 35.09 | 3.33M | 208,425 | — | ↗ |
| 2021-08-10 | Hinson Roger Mack | Officer | S-Sale | D | Common Stock | 8,799 | 32.35 | 284.6K | 116,129 | — | ↗ |
| 2021-07-12 | MEDEL ROGER MD | Director | F-InKind | D | Common Stock | 83,092 | 29.77 | 2.47M | 1,139,450 | — | ↗ |
| 2021-07-01 | MEDEL ROGER MD | Director | S-Sale | D | Common Stock | 100,000 | 30.31 | 3.03M | 1,222,542 | — | ↗ |
| 2021-06-01 | Pepia John C | Officer | F-InKind | D | Common Stock | 7,858 | 31.98 | 251.3K | 120,785 | — | ↗ |
| 2021-05-12 | Weis Shirley A | Director | A-Award | A | Common Stock | 4,885 | 0.00 | — | 17,223 | — | ↗ |
| 2021-05-12 | WALDEMAR, MD CARLO A | Director | A-Award | A | Common Stock | 4,885 | 0.00 | — | 36,687 | — | ↗ |
| 2021-05-12 | Starcher John M. Jr. | Director | A-Award | A | Common Stock | 4,885 | 0.00 | — | 16,832 | — | ↗ |
| 2021-05-12 | SANSONE GUY P | Director | A-Award | A | Common Stock | 4,885 | 0.00 | — | 30,516 | — | ↗ |
| 2021-05-12 | Rucker Michael A. | Director | A-Award | A | Common Stock | 4,885 | 0.00 | — | 20,347 | — | ↗ |
| 2021-05-12 | McEachin Thomas | Director | A-Award | A | Common Stock | 4,885 | 0.00 | — | 16,841 | — | ↗ |
| 2021-05-12 | MEDEL ROGER MD | Director | A-Award | A | Common Stock | 4,885 | 0.00 | — | 1,322,542 | — | ↗ |
| 2021-05-12 | Kadre Manuel | Director | A-Award | A | Common Stock | 4,885 | 0.00 | — | 129,198 | — | ↗ |
| 2021-05-12 | GABOS PAUL G | Director | A-Award | A | Common Stock | 4,885 | 0.00 | — | 29,198 | — | ↗ |
| 2021-05-12 | Barker Karey D | Director | A-Award | A | Common Stock | 4,885 | 0.00 | — | 22,663 | — | ↗ |
| 2021-04-01 | MEDEL ROGER MD | Director | S-Sale | D | Common Stock | 99,218 | 25.40 | 2.52M | 1,318,439 | — | ↗ |
| 2021-03-01 | Richards C Marc | Officer | A-Award | A | Common Stock | 28,571 | 0.00 | — | 52,069 | — | ↗ |
| 2021-03-01 | Pepia John C | Officer | A-Award | A | Common Stock | 10,204 | 0.00 | — | 120,653 | — | ↗ |
| 2021-03-01 | ORDAN MARK S | Director / Officer | A-Award | A | Common Stock | 71,429 | 0.00 | — | 136,996 | — | ↗ |
| 2021-03-01 | MEDEL ROGER MD | Director | F-InKind | D | Common Stock | 72,575 | 24.43 | 1.77M | 1,417,657 | — | ↗ |
| 2021-03-01 | Hinson Roger Mack | Officer | F-InKind | D | Common Stock | 6,244 | 24.43 | 152.5K | 124,800 | — | ↗ |
| 2021-03-01 | Andreano Dominic J | Officer | A-Award | A | Common Stock | 27,551 | 0.00 | — | 102,945 | — | ↗ |
| 2021-01-04 | MEDEL ROGER MD | Director | S-Sale | D | Common Stock | 47,039 | 23.41 | 1.10M | 1,543,193 | — | ↗ |
| 2020-12-10 | MEDEL ROGER MD | Director | S-Sale | D | Common Stock | 33,194 | 23.04 | 764.9K | 1,590,232 | — | ↗ |
| 2020-12-09 | MEDEL ROGER MD | Director | S-Sale | D | Common Stock | 66,806 | 23.00 | 1.54M | 1,623,426 | — | ↗ |
| 2020-10-01 | Richards C Marc | Officer | — | D | Common Stock | 0 | 0.00 | — | 23,498 | — | ↗ |
| 2020-09-27 | Hinson Roger Mack | Officer | — | D | Common Stock | 0 | 0.00 | — | 16,279 | — | ↗ |
| 2020-09-26 | Andreano Dominic J | Officer | A-Award | A | Common Stock | 21,686 | 0.00 | — | 75,394 | — | ↗ |
| 2020-09-15 | Nikolopoulos Nicholas J | Officer | S-Sale | D | Common Stock | 10,000 | 19.02 | 190.2K | 71,954 | — | ↗ |
| 2020-09-15 | Andreano Dominic J | Officer | S-Sale | D | Common Stock | 22,000 | 18.93 | 416.4K | 53,708 | — | ↗ |
| 2020-07-31 | FARBER STEPHEN D | Officer | G-Gift | D | Common Stock | 200,000 | 0.00 | — | 78,027 | — | ↗ |
| 2020-07-12 | Weis Shirley A | Director | — | D | Common Stock | 0 | 0.00 | — | 1,007 | — | ↗ |
| 2020-07-12 | Starcher John M. Jr. | Director | — | D | Common Stock | 0 | 0.00 | — | 616 | — | ↗ |
| 2020-07-12 | SANSONE GUY P | Director | — | D | Common Stock | 0 | 0.00 | — | 14,300 | — | ↗ |
| 2020-07-12 | ORDAN MARK S | Director / Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2020-07-12 | Nikolopoulos Nicholas | Officer | F-InKind | D | Common Stock | 53,174 | 17.65 | 938.5K | 81,954 | — | ↗ |
| 2020-07-12 | McEachin Thomas | Director | — | D | Common Stock | 0 | 0.00 | — | 625 | — | ↗ |
| 2020-07-12 | FARBER STEPHEN D | Officer | F-InKind | D | Common Stock | 151,581 | 17.65 | 2.68M | 278,027 | — | ↗ |
| 2020-07-12 | Andreano Dominic J | Officer | F-InKind | D | Common Stock | 32,413 | 17.65 | 572.1K | 75,708 | — | ↗ |
| 2020-06-02 | FARBER STEPHEN D | Officer | A-Award | A | Common Stock | 200,000 | 0.00 | — | 429,608 | — | ↗ |
| 2020-06-01 | Pepia John C | Officer | F-InKind | D | Common Stock | 329 | 15.53 | 5.1K | 110,449 | — | ↗ |
| 2020-06-01 | MEDEL ROGER MD | Director / Officer | F-InKind | D | Common Stock | 14,499 | 15.53 | 225.2K | 1,704,612 | — | ↗ |
| 2020-06-01 | Andreano Dominic J | Officer | F-InKind | D | Common Stock | 1,179 | 15.53 | 18.3K | 108,121 | — | ↗ |
| 2020-03-01 | Pepia John C | Officer | M-Exempt | A | Common Stock | 7,862 | 0.00 | — | 113,638 | — | ↗ |
| 2020-03-01 | MEDEL ROGER MD | Director / Officer | F-InKind | D | Common Stock | 43,137 | 17.09 | 737.2K | 1,719,111 | — | ↗ |
| 2020-03-01 | FARBER STEPHEN D | Officer | F-InKind | D | Common Stock | 9,134 | 17.09 | 156.1K | 229,608 | — | ↗ |
| 2020-03-01 | Andreano Dominic J | Officer | M-Exempt | D | Restricted Shares Units | 9,828 | 0.00 | — | 0 | — | ↗ |
| 2020-02-13 | WALDEMAR, MD CARLO A | Director | A-Award | A | Common Stock | 4,717 | 0.00 | — | 31,802 | — | ↗ |
| 2020-02-13 | SOSA ENRIQUE | Director | A-Award | A | Common Stock | 4,717 | 0.00 | — | 37,350 | — | ↗ |
| 2020-02-13 | Rucker Michael A. | Director | A-Award | A | Common Stock | 4,717 | 0.00 | — | 15,462 | — | ↗ |
| 2020-02-13 | Pepia John C | Officer | A-Award | A | Common Stock | 18,498 | 0.00 | — | 105,776 | — | ↗ |
| 2020-02-13 | Migoya Carlos A | Director | A-Award | A | Common Stock | 4,717 | 0.00 | — | 12,062 | — | ↗ |
| 2020-02-13 | MEDEL ROGER MD | Director / Officer | A-Award | A | Common Stock | 227,525 | 0.00 | — | 1,762,248 | — | ↗ |
| 2020-02-13 | Kadre Manuel | Director | A-Award | A | Common Stock | 4,717 | 0.00 | — | 124,313 | — | ↗ |
| 2020-02-13 | Goldschmidt, MD Pascal J | Director | A-Award | A | Common Stock | 4,717 | 0.00 | — | 15,538 | — | ↗ |
| 2020-02-13 | GABOS PAUL G | Director | A-Award | A | Common Stock | 4,717 | 0.00 | — | 24,313 | — | ↗ |
| 2020-02-13 | FERNANDEZ MICHAEL | Director | A-Award | A | Common Stock | 4,717 | 0.00 | — | 355,005 | — | ↗ |
| 2020-02-13 | FARBER STEPHEN D | Officer | A-Award | A | Common Stock | 88,791 | 0.00 | — | 238,742 | — | ↗ |
| 2020-02-13 | Barker Karey D | Director | A-Award | A | Common Stock | 4,717 | 0.00 | — | 17,778 | — | ↗ |
| 2020-02-13 | Andreano Dominic J | Officer | A-Award | A | Common Stock | 49,945 | 0.00 | — | 109,310 | — | ↗ |
| 2020-02-13 | ALVAREZ CESAR L | Director | A-Award | A | Common Stock | 4,717 | 0.00 | — | 48,403 | — | ↗ |
| 2019-12-01 | Clark David A. | Officer | F-InKind | D | Common Stock | 10,625 | 26.12 | 277.5K | 123,032 | — | ↗ |
| 2019-12-01 | Andreano Dominic J | Officer | F-InKind | D | Common Stock | 2,952 | 26.12 | 77.1K | 59,365 | — | ↗ |
| 2019-11-01 | Goldschmidt, MD Pascal J | Director | S-Sale | D | Common Stock | 5,000 | 22.88 | 114.4K | 10,821 | — | ↗ |
| 2019-09-03 | Goldschmidt, MD Pascal J | Director | S-Sale | D | Common Stock | 5,000 | 20.81 | 104.1K | 15,821 | — | ↗ |
| 2019-09-01 | FARBER STEPHEN D | Officer | F-InKind | D | Common Stock | 19,675 | 21.08 | 414.7K | 149,951 | — | ↗ |
| 2019-08-12 | FERNANDEZ MICHAEL | Director | P-Purchase | A | Common Stock | 61,205 | 21.35 | 1.31M | 350,288 | — | ↗ |
| 2019-08-09 | FERNANDEZ MICHAEL | Director | P-Purchase | A | Common Stock | 124,553 | 21.52 | 2.68M | 289,083 | — | ↗ |
| 2019-08-08 | FERNANDEZ MICHAEL | Director | P-Purchase | A | Common Stock | 64,242 | 21.68 | 1.39M | 164,530 | — | ↗ |
| 2019-06-01 | Pepia John C | Officer | A-Award | A | Common Stock | 50,690 | 0.00 | — | 86,758 | — | ↗ |
| 2019-06-01 | MEDEL ROGER MD | Director / Officer | F-InKind | D | Common Stock | 24,155 | 24.66 | 595.7K | 1,534,723 | — | ↗ |
| 2019-06-01 | Clark David A. | Officer | F-InKind | D | Common Stock | 3,307 | 24.66 | 81.6K | 133,657 | — | ↗ |
| 2019-06-01 | CALABRO JOSEPH M | Officer | F-InKind | D | Common Stock | 14,729 | 24.66 | 363.2K | 414,679 | — | ↗ |
| 2019-06-01 | Andreano Dominic J | Officer | F-InKind | D | Common Stock | 2,144 | 24.66 | 52.9K | 62,317 | — | ↗ |
| 2019-05-16 | Rucker Michael A. | Director | — | D | Common Stock | 0 | 0.00 | — | 10,745 | — | ↗ |
| 2019-05-16 | Migoya Carlos A | Director | — | D | Common Stock | 0 | 0.00 | — | 7,345 | — | ↗ |
| 2019-03-13 | Goldschmidt, MD Pascal J | Director | S-Sale | D | Common Stock | 3,300 | 30.40 | 100.3K | 20,821 | — | ↗ |
| 2019-03-07 | Andreano Dominic J | Officer | S-Sale | D | Common Stock | 4,608 | 30.16 | 139.0K | 64,461 | — | ↗ |
| 2019-03-01 | MEDEL ROGER MD | Director / Officer | F-InKind | D | Common Stock | 19,331 | 32.91 | 636.2K | 1,558,878 | — | ↗ |
| 2019-03-01 | Clark David A. | Officer | S-Sale | D | Common Stock | 6,452 | 32.90 | 212.3K | 136,964 | — | ↗ |
| 2019-03-01 | CALABRO JOSEPH M | Officer | S-Sale | D | Common Stock | 12,130 | 32.91 | 399.2K | 429,408 | — | ↗ |
| 2019-02-28 | WALDEMAR, MD CARLO A | Director | M-Exempt | A | Stock Options (Right to Buy) | 17,584 | 18.91 | 332.5K | 0 | — | ↗ |
| 2019-02-27 | SOSA ENRIQUE | Director | M-Exempt | A | Stock Options (Right to Buy) | 17,584 | 18.91 | 332.5K | 0 | — | ↗ |
| 2019-02-20 | Andreano Dominic J | Officer | S-Sale | D | Common Stock | 1,289 | 36.22 | 46.7K | 69,069 | — | ↗ |
| 2019-02-12 | WALDEMAR, MD CARLO A | Director | A-Award | A | Common Stock | 3,699 | 0.00 | — | 19,596 | — | ↗ |
| 2019-02-12 | SOSA ENRIQUE | Director | A-Award | A | Common Stock | 3,699 | 0.00 | — | 25,005 | — | ↗ |
Executive team
Executive compensation
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2025 | Mark S. Ordan Chief Executive Officer | 970.0K | 2.00M | 8.46M | — | 2.70M | 14.2K | 14.14M | 59.80% | ↗ |
| 2 | 2025 | Don Gregory Neeb Executive Vice President, Chief Investment & Strategy Officer | 229.2K | 1.00M | 3.57M | — | 518.7K | 125.00 | 5.32M | 67.13% | ↗ |
| 3 | 2025 | Mary Ann E. Moore Executive Vice President, General Counsel, Chief Administrative Officer and Secretary | 500.0K | — | 1.39M | — | 1.13M | 14.2K | 3.03M | 45.92% | ↗ |
| 4 | 2025 | James D. Swift, M.D. Former Chief Executive Officer | 54.2K | — | 730.7K | — | 69.0K | 1.92M | 2.78M | 26.32% | ↗ |
| 5 | 2025 | Kasandra H. Rossi Executive Vice President, Chief Financial Officer & Treasurer | 437.5K | — | 598.3K | — | 810.0K | 14.3K | 1.86M | 32.16% | ↗ |
| 6 | 2024 | James D. Swift, M.D. Former Chief Executive Officer | 650.0K | — | 1.18M | — | 1.46M | 8.4K | 3.30M | 35.75% | ↗ |
| 7 | 2024 | C. Marc Richards Former Executive Vice President, Chief Financial Officer | 375.0K | — | 1.07M | — | 375.3K | 955.5K | 2.78M | 38.65% | ↗ |
| 8 | 2024 | Mary Ann E. Moore Executive Vice President, General Counsel, Chief Administrative Officer and Secretary | 485.4K | — | 767.5K | — | 1.13M | 10.6K | 2.39M | 32.13% | ↗ |
| 9 | 2024 | Curtis B. Pickert, M.D. Former Executive Vice President, Chief Physician Executive | 500.0K | — | 767.5K | — | 868.6K | 10.5K | 2.15M | 35.75% | ↗ |
| 10 | 2024 | Lee A. Wood Former Executive Vice President, National and Market Operations | 220.6K | — | 575.7K | — | 163.3K | 772.7K | 1.73M | 33.23% | ↗ |
| 11 | 2024 | Kasandra H. Rossi Executive Vice President, Chief Financial Officer & Treasurer | 368.8K | — | 391.7K | — | 573.8K | 10.6K | 1.34M | 29.13% | ↗ |
| 12 | 2023 | James D. Swift, M.D. Chief Executive Officer | 650.0K | 390.0K | 1.03M | — | 162.5K | 10.3K | 2.24M | 45.80% | ↗ |
| 13 | 2023 | James D. Swift, M.D. Former Chief Executive Officer | 650.0K | 390.0K | 1.03M | — | 162.5K | 10.3K | 2.24M | 45.80% | ↗ |
| 14 | 2023 | Curtis B. Pickert, M.D. Executive Vice President, Chief Operating Officer | 500.0K | 240.0K | 1.03M | — | 100.0K | 10.2K | 1.88M | 54.70% | ↗ |
| 15 | 2023 | Curtis B. Pickert, M.D. Former Executive Vice President, Chief Physician Executive | 500.0K | 240.0K | 1.03M | — | 100.0K | 10.2K | 1.88M | 54.70% | ↗ |
| 16 | 2023 | Mary Ann E. Moore Executive Vice President, General Counsel, Chief Administrative Officer and Secretary | 475.0K | 228.0K | 1.03M | — | 95.0K | 10.3K | 1.83M | 55.95% | ↗ |
| 17 | 2023 | Mary Ann E. Moore Executive Vice President, General Counsel and Secretary | 475.0K | 228.0K | 1.03M | — | 95.0K | 10.3K | 1.83M | 55.95% | ↗ |
| 18 | 2023 | C. Marc Richards Former Executive Vice President, Chief Financial Officer | 500.0K | 240.0K | 933.4K | — | 100.0K | 10.3K | 1.78M | 52.33% | ↗ |
| 19 | 2023 | C. Marc Richards Executive Vice President and Chief Financial Officer | 500.0K | 240.0K | 933.4K | — | 100.0K | 10.3K | 1.78M | 52.33% | ↗ |
| 20 | 2023 | Lee A. Wood Executive Vice President, National and Market Operations | 425.0K | 153.0K | 740.0K | — | 63.8K | 10.3K | 1.39M | 53.16% | ↗ |
| 21 | 2023 | Lee A. Wood Former Executive Vice President, National and Market Operations | 425.0K | 153.0K | 740.0K | — | 63.8K | 10.3K | 1.39M | 53.16% | ↗ |
| 22 | 2022 | Mark S. Ordan Executive Chair (Former Chief Executive Officer) | 1.00M | — | 3.50M | — | — | 155.7K | 4.66M | 75.18% | ↗ |
| 23 | 2022 | Dominic J. Andreano Former Executive Vice President, General Counsel and Secretary | 395.8K | — | 1.35M | — | 394.5K | 81.1K | 2.22M | 60.77% | ↗ |
| 24 | 2022 | C. Marc Richards Executive Vice President and Chief Financial Officer | 500.0K | — | 1.40M | — | — | 9.6K | 1.91M | 73.31% | ↗ |
| 25 | 2022 | C. Marc Richards Former Executive Vice President, Chief Financial Officer | 500.0K | — | 1.40M | — | — | 9.6K | 1.91M | 73.31% | ↗ |
| 26 | 2022 | James D. Swift, M.D. Former Chief Executive Officer | 450.0K | — | 825.0K | — | 90.0K | 9.5K | 1.37M | 60.02% | ↗ |
| 27 | 2022 | James D. Swift, M.D. Chief Executive Officer (Former Executive Vice President and Chief Operating Officer) | 450.0K | — | 825.0K | — | 90.0K | 9.5K | 1.37M | 60.02% | ↗ |
| 28 | 2022 | James D. Swift, M.D. Chief Executive Officer | 450.0K | — | 825.0K | — | 90.0K | 9.5K | 1.37M | 60.02% | ↗ |
| 29 | 2022 | Mary Ann E. Moore Executive Vice President, General Counsel, Chief Administrative Officer and Secretary | 437.5K | — | 750.0K | — | 95.0K | 9.5K | 1.29M | 58.05% | ↗ |
| 30 | 2022 | Mary Ann E. Moore Executive Vice President, General Counsel and Secretary | 437.5K | — | 750.0K | — | 95.0K | 9.5K | 1.29M | 58.05% | ↗ |
| 31 | 2022 | Mary Ann E. Moore Executive Vice President, General Counsel and Secretary (Former Executive Vice President, Chief Enterprise Risk and Legal Operations Officer) | 437.5K | — | 750.0K | — | 95.0K | 9.5K | 1.29M | 58.05% | ↗ |
| 32 | 2021 | Mark S. Ordan Chief Executive Officer | 1.00M | — | 3.50M | — | 2.34M | 8.9K | 6.85M | 51.10% | ↗ |
| 33 | 2021 | Mark S. Ordan Executive Chair (Former Chief Executive Officer) | 1.00M | — | 3.50M | — | 2.34M | 8.9K | 6.85M | 51.10% | ↗ |
| 34 | 2021 | Roger Mack Hinson, M.D. President, Pediatrix and Obstetrix Medical Group | 550.0K | — | 1.50M | — | 858.0K | 8.9K | 2.92M | 51.42% | ↗ |
| 35 | 2021 | C. Marc Richards Executive Vice President and Chief Financial Officer | 500.0K | — | 1.40M | — | 780.0K | 8.9K | 2.69M | 52.07% | ↗ |
| 36 | 2021 | Dominic J. Andreano Former Executive Vice President, General Counsel and Secretary | 500.0K | — | 1.35M | — | 780.0K | 8.9K | 2.64M | 51.16% | ↗ |
| 37 | 2021 | Dominic J. Andreano Executive Vice President, General Counsel and Secretary | 500.0K | — | 1.35M | — | 780.0K | 8.9K | 2.64M | 51.16% | ↗ |
| 38 | 2021 | John C. Pepia Senior Vice President and Chief Accounting Officer (former Principal Accounting Officer) | 425.0K | — | 500.0K | — | 497.3K | 8.9K | 1.43M | 34.94% | ↗ |
| 39 | 2021 | Mary Ann E. Moore Executive Vice President, General Counsel and Secretary (Former Executive Vice President, Chief Enterprise Risk and Legal Operations Officer) | 364.9K | — | 200.0K | — | 286.0K | 8.9K | 859.9K | 23.26% | ↗ |
| 40 | 2021 | Mary Ann E. Moore Executive Vice President, General Counsel and Secretary | 364.9K | — | 200.0K | — | 286.0K | 8.9K | 859.9K | 23.26% | ↗ |
| 41 | 2021 | Mary Ann E. Moore Executive Vice President, Enterprise Risk and Legal Operations Officer | 364.9K | — | 200.0K | — | 286.0K | 8.9K | 859.9K | 23.26% | ↗ |
| 42 | 2020 | Roger J. Medel, M.D. Former Chief Executive Officer | 1.00 | — | 6.15M | — | 780.8K | 666.4K | 7.60M | 80.95% | ↗ |
| 43 | 2020 | Stephen D. Farber Former Executive Vice President and Chief Financial Officer | 345.8K | — | 5.69M | — | 413.3K | 590.1K | 7.04M | 80.84% | ↗ |
| 44 | 2020 | Mark S. Ordan Executive Chair (Former Chief Executive Officer) | 471.0K | — | 2.00M | 3.00M | 709.0K | 258.7K | 6.44M | 77.66% | ↗ |
| 45 | 2020 | Mark S. Ordan Chief Executive Officer | 471.0K | — | 2.00M | 3.00M | 709.0K | 258.7K | 6.44M | 77.66% | ↗ |
| 46 | 2020 | Dominic J. Andreano Former Executive Vice President, General Counsel and Secretary | 431.3K | — | 1.70M | 470.9K | 500.0K | 274.8K | 3.38M | 64.29% | ↗ |
| 47 | 2020 | Dominic J. Andreano Executive Vice President, General Counsel and Secretary | 431.3K | — | 1.70M | 470.9K | 500.0K | 274.8K | 3.38M | 64.29% | ↗ |
| 48 | 2020 | Roger Mack Hinson, M.D. President, Pediatrix and Obstetrix Medical Group | 432.8K | — | 965.0K | 706.6K | 550.0K | 258.8K | 2.91M | 57.38% | ↗ |
| 49 | 2020 | Nicholas J. Nikolopoulos Former Executive Vice President and Chief Strategy & Growth Officer | 431.3K | — | 1.30M | — | 500.0K | 349.2K | 2.58M | 50.38% | ↗ |
| 50 | 2020 | C. Marc Richards Executive Vice President and Chief Financial Officer | 157.2K | — | 700.0K | 944.1K | 157.1K | 8.6K | 1.97M | 83.58% | ↗ |
| 51 | 2020 | John C. Pepia Senior Vice President and Chief Accounting Officer (former Principal Accounting Officer) | 371.9K | — | 500.0K | — | 318.8K | 108.8K | 1.30M | 38.48% | ↗ |
| 52 | 2020 | John C. Pepia Senior Vice President and Chief Accounting Officer | 371.9K | — | 500.0K | — | 318.8K | 108.8K | 1.30M | 38.48% | ↗ |
| 53 | 2019 | Roger J. Medel, M.D. Former Chief Executive Officer | 500.0K | — | 6.15M | — | 1.13M | 291.2K | 8.07M | 76.24% | ↗ |
| 54 | 2019 | Joseph M. Calabro Former President | 300.0K | — | 3.75M | — | 223.2K | 538.9K | 4.81M | 77.93% | ↗ |
| 55 | 2019 | Stephen D. Farber Executive Vice President and Chief Financial Officer | 550.0K | — | 2.40M | — | 412.5K | 36.6K | 3.40M | 70.61% | ↗ |
| 56 | 2019 | Stephen D. Farber Former Executive Vice President and Chief Financial Officer | 550.0K | — | 2.40M | — | 412.5K | 36.6K | 3.40M | 70.61% | ↗ |
| 57 | 2019 | David A. Clark Former Chief Operating Officer | 525.0K | — | 1.95M | — | 393.8K | 8.6K | 2.88M | 67.77% | ↗ |
| 58 | 2019 | John C. Pepia Senior Vice President and Chief Accounting Officer | 406.2K | — | 1.50M | — | 159.4K | 8.6K | 2.07M | 72.32% | ↗ |
| 59 | 2019 | John C. Pepia Senior Vice President and Chief Accounting Officer (former Principal Accounting Officer) | 406.2K | — | 1.50M | — | 159.4K | 8.6K | 2.07M | 72.32% | ↗ |
| 60 | 2019 | Dominic J. Andreano Executive Vice President, General Counsel and Secretary | 475.0K | — | 1.05M | — | 356.3K | 8.6K | 1.89M | 55.56% | ↗ |
| 61 | 2018 | Roger J. Medel, M.D. Former Chief Executive Officer | 1.00M | — | 8.00M | — | 669.0K | 269.0K | 9.94M | 80.50% | ↗ |
| 62 | 2018 | Roger J. Medel, M.D. Chief Executive Officer | 1.00M | — | 8.00M | — | 669.0K | 269.0K | 9.94M | 80.50% | ↗ |
| 63 | 2018 | Joseph M. Calabro Former President | 600.0K | — | 5.00M | — | 267.6K | 155.8K | 6.02M | 83.01% | ↗ |
| 64 | 2018 | Joseph M. Calabro President | 600.0K | — | 5.00M | — | 267.6K | 155.8K | 6.02M | 83.01% | ↗ |
| 65 | 2018 | Stephen D. Farber Former Executive Vice President and Chief Financial Officer | 192.9K | — | 4.76M | — | 191.4K | 607.4K | 5.75M | 82.75% | ↗ |
| 66 | 2018 | Stephen D. Farber Executive Vice President and Chief Financial Officer | 192.9K | — | 4.76M | — | 191.4K | 607.4K | 5.75M | 82.75% | ↗ |
| 67 | 2018 | David A. Clark Former Chief Operating Officer | 483.3K | — | 3.22M | — | 234.2K | 11.3K | 3.95M | 81.55% | ↗ |
| 68 | 2018 | David A. Clark Chief Operating Officer | 483.3K | — | 3.22M | — | 234.2K | 11.3K | 3.95M | 81.55% | ↗ |
| 69 | 2018 | Vivian Lopez-Blanco. Former Chief Financial Officer and Treasurer | 475.0K | — | 2.00M | — | 211.9K | 11.3K | 2.70M | 74.13% | ↗ |
| 70 | 2018 | Dominic J. Andreano Senior Vice President, General Counsel and Secretary | 433.3K | — | 1.35M | — | 211.9K | 11.3K | 2.01M | 67.33% | ↗ |
| 71 | 2018 | Dominic J. Andreano Executive Vice President, General Counsel and Secretary | 433.3K | — | 1.35M | — | 211.9K | 11.3K | 2.01M | 67.33% | ↗ |
| 72 | 2017 | Roger J. Medel, M.D. Former Chief Executive Officer | 1.00M | — | 6.15M | — | — | 215.5K | 7.37M | 83.50% | ↗ |
| 73 | 2017 | Roger J. Medel, M.D. Chief Executive Officer | 1.00M | — | 6.15M | — | — | 215.5K | 7.37M | 83.50% | ↗ |
| 74 | 2017 | Joseph M. Calabro Former President | 600.0K | — | 3.75M | — | — | 90.8K | 4.44M | 84.44% | ↗ |
| 75 | 2017 | Joseph M. Calabro President | 600.0K | — | 3.75M | — | — | 90.8K | 4.44M | 84.44% | ↗ |
| 76 | 2017 | Joseph M. Calabro President and Chief Operating Officer | 600.0K | — | 3.75M | — | — | 90.8K | 4.44M | 84.44% | ↗ |
| 77 | 2017 | David A. Clark Former Chief Operating Officer | 450.0K | — | 1.60M | — | 337.5K | 18.3K | 2.41M | 66.51% | ↗ |
| 78 | 2017 | David A. Clark President, MEDNAX National Medical Group | 450.0K | — | 1.60M | — | 337.5K | 18.3K | 2.41M | 66.51% | ↗ |
| 79 | 2017 | David A. Clark Chief Operating Officer | 450.0K | — | 1.60M | — | 337.5K | 18.3K | 2.41M | 66.51% | ↗ |
| 80 | 2017 | Vivian Lopez-Blanco. Chief Financial Officer and Treasurer | 475.0K | — | 1.30M | — | — | 11.1K | 1.79M | 72.79% | ↗ |
| 81 | 2017 | Vivian Lopez-Blanco. Former Chief Financial Officer and Treasurer | 475.0K | — | 1.30M | — | — | 11.1K | 1.79M | 72.79% | ↗ |
| 82 | 2017 | Dominic J. Andreano Senior Vice President, General Counsel and Secretary | 350.0K | — | 1.00M | — | 196.9K | 11.1K | 1.56M | 64.19% | ↗ |
| 83 | 2017 | Dominic J. Andreano Executive Vice President, General Counsel and Secretary | 350.0K | — | 1.00M | — | 196.9K | 11.1K | 1.56M | 64.19% | ↗ |
| 84 | 2016 | Roger J. Medel, M.D. Chief Executive Officer | 1.00M | — | 6.15M | — | 444.0K | 230.8K | 7.82M | 78.60% | ↗ |
| 85 | 2016 | Joseph M. Calabro President | 600.0K | — | 3.75M | — | 177.6K | 142.7K | 4.67M | 80.29% | ↗ |
| 86 | 2016 | Joseph M. Calabro President and Chief Operating Officer | 600.0K | — | 3.75M | — | 177.6K | 142.7K | 4.67M | 80.29% | ↗ |
| 87 | 2016 | Karl B. Wagner President, Eastern Division | 500.0K | — | 1.63M | — | 148.0K | 13.0K | 2.29M | 71.09% | ↗ |
| 88 | 2016 | Vivian Lopez-Blanco. Chief Financial Officer and Treasurer | 454.2K | — | 1.30M | — | 140.6K | 13.3K | 1.91M | 68.13% | ↗ |
| 89 | 2016 | Vivian Lopez-Blanco Chief Financial Officer and Treasurer | 454.2K | — | 1.30M | — | 140.6K | 13.3K | 1.91M | 68.13% | ↗ |
| 90 | 2016 | Vivian Lopez-Blanco. Former Chief Financial Officer and Treasurer | 454.2K | — | 1.30M | — | 140.6K | 13.3K | 1.91M | 68.13% | ↗ |
| 91 | 2016 | Michael D. Stanley, M.D. President, Clinical Services Division | 450.0K | — | 825.1K | — | 99.9K | 15.4K | 1.39M | 59.34% | ↗ |
| 92 | 2015 | Roger J. Medel, M.D. Chief Executive Officer | 1.00M | — | 6.15M | — | 1.69M | 172.9K | 9.01M | 68.25% | ↗ |
| 93 | 2015 | Joseph M. Calabro President and Chief Operating Officer | 600.0K | — | 3.75M | — | 675.0K | 60.5K | 5.09M | 73.74% | ↗ |
| 94 | 2015 | Karl B. Wagner President, Eastern Division | 500.0K | — | 1.63M | — | 562.5K | 12.7K | 2.70M | 60.18% | ↗ |
| 95 | 2015 | Vivian Lopez-Blanco Chief Financial Officer and Treasurer | 425.0K | — | 1.15M | — | 478.1K | 12.8K | 2.07M | 55.67% | ↗ |
| 96 | 2015 | Vivian Lopez-Blanco. Chief Financial Officer and Treasurer | 425.0K | — | 1.15M | — | 478.1K | 12.8K | 2.07M | 55.67% | ↗ |
| 97 | 2015 | Michael D. Stanley, M.D. President, Clinical Services Division | 450.0K | — | 825.0K | — | 379.7K | 12.5K | 1.67M | 49.49% | ↗ |
| 98 | 2015 | Michael D. Stanley, M.D President, Clinical Services Division | 450.0K | — | 825.0K | — | 379.7K | 12.5K | 1.67M | 49.49% | ↗ |
| 99 | 2014 | Roger J. Medel, M.D. Chief Executive Officer | 1.00M | — | 6.15M | — | 1.92M | 156.9K | 9.22M | 66.68% | ↗ |
| 100 | 2014 | Joseph M. Calabro President and Chief Operating Officer | 600.0K | — | 3.75M | — | 766.6K | 79.5K | 5.20M | 72.17% | ↗ |
| 101 | 2014 | Karl B. Wagner President, Eastern Division | 500.0K | — | 1.40M | — | 575.0K | 12.6K | 2.49M | 56.28% | ↗ |
| 102 | 2014 | Karl B. Wagner President, American Anesthesiology | 500.0K | — | 1.40M | — | 575.0K | 12.6K | 2.49M | 56.28% | ↗ |
| 103 | 2014 | Vivian Lopez-Blanco Chief Financial Officer and Treasurer | 414.6K | — | 1.15M | — | 543.0K | 12.9K | 2.12M | 54.23% | ↗ |
| 104 | 2014 | Vivian Lopez-Blanco. Chief Financial Officer and Treasurer | 414.6K | — | 1.15M | — | 543.0K | 12.9K | 2.12M | 54.23% | ↗ |
| 105 | 2014 | Michael D. Stanley, M.D President, Clinical Services Division | 450.0K | — | 825.0K | — | 388.1K | 18.2K | 1.68M | 49.07% | ↗ |
| 106 | 2014 | Michael D. Stanley, M.D President, Pediatrix Medical Group | 450.0K | — | 825.0K | — | 388.1K | 18.2K | 1.68M | 49.07% | ↗ |
| 107 | 2014 | Michael D. Stanley, M.D. President, Pediatrix Medical Group | 450.0K | — | 825.0K | — | 388.1K | 18.2K | 1.68M | 49.07% | ↗ |
| 108 | 2014 | Michael D. Stanley, M.D. President, Clinical Services Division | 450.0K | — | 825.0K | — | 388.1K | 18.2K | 1.68M | 49.07% | ↗ |
| 109 | 2013 | Roger J. Medel, M.D. Chief Executive Officer | 1.00M | — | 6.15M | — | 1.50M | 196.8K | 8.85M | 69.52% | ↗ |
| 110 | 2013 | Joseph M. Calabro President and Chief Operating Officer | 600.0K | — | 3.75M | — | 600.0K | 62.1K | 5.01M | 74.82% | ↗ |
| 111 | 2013 | Chief Executive Officer | 600.0K | — | 3.75M | — | 600.0K | 62.1K | 5.01M | 74.82% | ↗ |
| 112 | 2013 | Karl B. Wagner President, Eastern Division | 500.0K | — | 1.62M | — | 500.0K | 13.1K | 2.64M | 61.60% | ↗ |
| 113 | 2013 | Vivian Lopez-Blanco. Chief Financial Officer and Treasurer Joseph M. Calabro President and Chief Operating Officer Karl B. Wagner President, American Anesthesiology | 500.0K | — | 1.62M | — | 500.0K | 13.1K | 2.64M | 61.60% | ↗ |
| 114 | 2013 | Karl B. Wagner President, American Anesthesiology | 500.0K | — | 1.62M | — | 500.0K | 13.1K | 2.64M | 61.60% | ↗ |
| 115 | 2013 | Vivian Lopez-Blanco. Chief Financial Officer and Treasurer | 400.0K | — | 1,000.0K | — | 400.0K | 13.3K | 1.81M | 55.15% | ↗ |
| 116 | 2013 | Vivian Lopez-Blanco Chief Financial Officer and Treasurer | 400.0K | — | 1,000.0K | — | 400.0K | 13.3K | 1.81M | 55.15% | ↗ |
| 117 | 2013 | Michael D. Stanley, M.D. President, Pediatrix Medical Group | 450.0K | — | 812.5K | — | 337.5K | 13.1K | 1.61M | 50.37% | ↗ |
| 118 | 2013 | Michael D. Stanley, M.D President, Clinical Services Division | 450.0K | — | 812.5K | — | 337.5K | 13.1K | 1.61M | 50.37% | ↗ |
| 119 | 2013 | Michael D. Stanley, M.D President, Pediatrix Medical Group | 450.0K | — | 812.5K | — | 337.5K | 13.1K | 1.61M | 50.37% | ↗ |
| 120 | 2012 | Roger J. Medel, M.D. Chief Executive Officer | 1.00M | — | 6.15M | — | 1.69M | 160.0K | 9.00M | 68.33% | ↗ |
| 121 | 2012 | Roger J. Medel, M.D. Chief Executive Officer | 1.00M | — | 6.15M | — | 1.69M | 160.0K | 9.00M | 68.33% | ↗ |
| 122 | 2012 | Joseph M. Calabro President and Chief Operating Officer | 600.0K | — | 3.75M | — | 676.0K | 131.1K | 5.16M | 72.72% | ↗ |
| 123 | 2012 | Chief Executive Officer | 600.0K | — | 3.75M | — | 676.0K | 131.1K | 5.16M | 72.72% | ↗ |
| 124 | 2012 | Vivian Lopez-Blanco. Chief Financial Officer and Treasurer Joseph M. Calabro President and Chief Operating Officer Karl B. Wagner President, American Anesthesiology | 500.0K | — | 1.63M | — | 563.3K | 13.0K | 2.70M | 60.16% | ↗ |
| 125 | 2012 | Karl B. Wagner President, American Anesthesiology | 500.0K | — | 1.63M | — | 563.3K | 13.0K | 2.70M | 60.16% | ↗ |
| 126 | 2012 | Vivian Lopez-Blanco Chief Financial Officer and Treasurer | 375.0K | — | 750.0K | — | 422.5K | 13.4K | 1.56M | 48.05% | ↗ |
| 127 | 2012 | Michael D. Stanley, M.D. President, Pediatrix Medical Group | 446.5K | — | 712.5K | — | 380.2K | 16.0K | 1.56M | 45.81% | ↗ |
| 128 | 2012 | Michael D. Stanley, M.D President, Pediatrix Medical Group | 446.5K | — | 712.5K | — | 380.2K | 16.0K | 1.56M | 45.81% | ↗ |
| 129 | 2012 | Michael D. Stanley, M.D President, Pediatrix Division | 446.5K | — | 712.5K | — | 380.2K | 16.0K | 1.56M | 45.81% | ↗ |
| 130 | 2011 | Roger J. Medel, M.D. Chief Executive Officer | 969.9K | — | 9.70M | — | 1.46M | 308.0K | 12.43M | 78.01% | ↗ |
| 131 | 2011 | Roger J. Medel, M.D. Chief Executive Officer | 969.9K | — | 9.70M | — | 1.46M | 308.0K | 12.43M | 78.02% | ↗ |
| 132 | 2011 | Chief Executive Officer | 600.0K | — | 2.45M | — | 600.0K | 139.9K | 3.79M | 64.65% | ↗ |
| 133 | 2011 | Joseph M. Calabro President and Chief Operating Officer | 600.0K | — | 2.45M | — | 600.0K | 139.9K | 3.79M | 64.65% | ↗ |
| 134 | 2011 | Karl B. Wagner President, American Anesthesiology, Inc. | 500.0K | — | 1.62M | — | 500.0K | 35.5K | 2.66M | 61.08% | ↗ |
| 135 | 2011 | Vivian Lopez-Blanco. Chief Financial Officer and Treasurer Joseph M. Calabro President and Chief Operating Officer Karl B. Wagner President, American Anesthesiology | 500.0K | — | 1.62M | — | 500.0K | 35.5K | 2.66M | 61.08% | ↗ |
| 136 | 2011 | Thomas W. Hawkins Senior Vice President, General Counsel and Secretary | 425.0K | — | 1.22M | — | 425.0K | 16.1K | 2.09M | 58.48% | ↗ |
| 137 | 2011 | Vivian Lopez-Blanco Chief Financial Officer and Treasurer | 325.0K | — | 575.0K | — | 325.0K | 17.2K | 1.24M | 46.29% | ↗ |
| 138 | 2010 | Roger J. Medel, M.D. Chief Executive Officer | 950.0K | — | 4.10M | — | 1.14M | 336.5K | 6.53M | 62.82% | ↗ |
| 139 | 2010 | Joseph M. Calabro President and Chief Operating Officer | 600.0K | — | 2.45M | — | 480.0K | 201.2K | 3.73M | 65.66% | ↗ |
| 140 | 2010 | Karl B. Wagner President, American Anesthesiology, Inc. | 500.0K | — | 1.63M | — | 400.0K | 34.5K | 2.56M | 63.49% | ↗ |
| 141 | 2010 | Thomas W. Hawkins Senior Vice President, General Counsel and Secretary | 425.0K | — | 1.22M | — | 340.0K | 399.00 | 1.99M | 61.45% | ↗ |
| 142 | 2010 | Vivian Lopez-Blanco. Chief Financial Officer and Treasurer Joseph M. Calabro President and Chief Operating Officer Karl B. Wagner President, American Anesthesiology | 300.0K | — | 465.0K | — | 180.0K | 15.3K | 960.3K | 48.42% | ↗ |
| 143 | 2010 | Vivian Lopez-Blanco Chief Financial Officer and Treasurer | 300.0K | — | 465.0K | — | 180.0K | 15.3K | 960.3K | 48.42% | ↗ |
| 144 | 2009 | Roger J. Medel, M.D. Chief Executive Officer | 950.0K | — | 4.10M | — | 2.85M | 223.0K | 8.12M | 50.47% | ↗ |
| 145 | 2009 | Joseph M. Calabro President and Chief Operating Officer | 600.0K | — | 2.45M | — | 1.20M | 67.1K | 4.32M | 56.75% | ↗ |
| 146 | 2009 | Karl B. Wagner Chief Financial Officer | 500.0K | — | 1.62M | — | 1.00M | 23.6K | 3.15M | 51.61% | ↗ |
| 147 | 2009 | Karl B. Wagner President, American Anesthesiology, Inc. | 500.0K | — | 1.62M | — | 1.00M | 23.6K | 3.15M | 51.61% | ↗ |
| 148 | 2009 | Thomas W. Hawkins Senior Vice President, General Counsel and Secretary | 425.0K | — | 1.22M | — | 850.0K | 420.00 | 2.50M | 48.89% | ↗ |
| 149 | 2009 | Frederick V. Miller, M.D. | 425.0K | — | 619.2K | — | 478.1K | 10.2K | 1.53M | 40.40% | ↗ |
| 150 | 2008 | Roger J. Medel, M.D. Chief Executive Officer | 887.5K | 138.3K | 7.80M | 1.77M | 336.7K | 146.5K | 11.07M | 86.37% | ↗ |
| 151 | 2008 | Roger J. Medel, M.D Chief Executive Officer | 887.5K | 138.3K | 1.94M | 1.16M | 336.7K | 146.5K | 4.61M | 67.25% | ↗ |
| 152 | 2008 | Joseph M. Calabro President and Chief Operating Officer | 564.6K | 68.2K | 1.35M | 1.06M | 141.8K | 9.6K | 3.19M | 75.42% | ↗ |
| 153 | 2008 | Karl B. Wagner President, American Anesthesiology, Inc. | 470.8K | 56.9K | 898.4K | 706.0K | 118.2K | 9.6K | 2.26M | 71.00% | ↗ |
| 154 | 2008 | Karl B. Wagner Chief Financial Officer | 470.8K | 56.9K | 898.4K | 706.0K | 118.2K | 9.6K | 2.26M | 71.00% | ↗ |
| 155 | 2008 | Thomas W. Hawkins Senior Vice President, General Counsel and Secretary | 414.6K | 48.3K | 673.8K | 529.5K | 100.4K | 420.00 | 1.77M | 68.10% | ↗ |
| 156 | 2007 | Roger J. Medel, M.D. Chief Executive Officer | 800.0K | 89.6K | 1.13M | 589.9K | 799.2K | 83.3K | 3.49M | 49.28% | ↗ |
| 157 | 2007 | Roger J. Medel, M.D Chief Executive Officer | 800.0K | 89.6K | 1.13M | 589.9K | 799.2K | 83.3K | 3.49M | 49.28% | ↗ |
| 158 | 2007 | Roger J. Medel, M.D. Chief Executive Officer | 800.0K | 89.6K | 934.2K | 763.5K | 799.2K | 83.3K | 3.47M | 48.93% | ↗ |
| 159 | 2007 | Joseph M. Calabro President and Chief Operating Officer | 515.0K | 57.7K | 1.40M | 572.6K | 514.5K | 31.5K | 3.09M | 63.83% | ↗ |
| 160 | 2007 | Joseph M. Calabro President and Chief Operating Officer | 515.0K | 57.7K | 848.7K | 442.4K | 514.5K | 31.5K | 2.41M | 53.58% | ↗ |
| 161 | 2007 | Karl B. Wagner Chief Financial Officer and Treasurer | 430.0K | 48.2K | 636.5K | 331.8K | 429.6K | 9.4K | 1.89M | 51.36% | ↗ |
| 162 | 2007 | Karl B. Wagner Chief Financial Officer | 430.0K | 48.2K | 525.5K | 429.5K | 429.6K | 9.4K | 1.87M | 51.01% | ↗ |
| 163 | 2007 | Thomas W. Hawkins Senior Vice President, General Counsel and Secretary | 400.0K | 44.8K | 565.7K | 294.9K | 399.6K | 420.00 | 1.71M | 50.47% | ↗ |
| 164 | 2007 | Thomas W. Hawkins Senior Vice President, General Counsel and Secretary | 400.0K | 44.8K | 467.1K | 381.8K | 399.6K | 420.00 | 1.69M | 50.12% | ↗ |
| 165 | 2006 | Roger J. Medel, M.D. Chief Executive Officer | 800.0K | — | 1.48M | 669.0K | 945.8K | 50.5K | 3.94M | 54.45% | ↗ |
| 166 | 2006 | Roger J. Medel, M.D Chief Executive Officer | 800.0K | — | 1.48M | 669.0K | 945.8K | 50.5K | 3.94M | 54.45% | ↗ |
| 167 | 2006 | Joseph M. Calabro President and Chief Operating Officer | 515.0K | — | 1.48M | 456.0K | 608.9K | 9.4K | 3.07M | 63.05% | ↗ |
| 168 | 2006 | Joseph M. Calabro President and Chief Operating Officer | 515.0K | — | 1.48M | 456.0K | 608.9K | 9.4K | 3.07M | 63.05% | ↗ |
| 169 | 2006 | Roger J. Medel, M.D. Chief Executive Officer | 800.0K | — | 1.48M | — | 945.8K | 50.5K | 3.00M | 49.31% | ↗ |
| 170 | 2006 | Karl B. Wagner Chief Financial Officer | 430.0K | — | 1.11M | 342.0K | 508.4K | 9.4K | 2.40M | 60.47% | ↗ |
| 171 | 2006 | Karl B. Wagner Chief Financial Officer and Treasurer | 430.0K | — | 1.11M | 342.0K | 508.4K | 9.4K | 2.40M | 60.47% | ↗ |
| 172 | 2006 | Thomas W. Hawkins Senior Vice President, General Counsel and Secretary | 400.0K | — | 739.2K | 365.5K | 472.9K | 624.00 | 1.98M | 55.84% | ↗ |
| 173 | 2006 | Thomas W. Hawkins Senior Vice President, General Counsel and Secretary | 400.0K | — | 739.2K | 365.5K | 472.9K | 624.00 | 1.98M | 55.84% | ↗ |
| 174 | 2005 | Joseph M. Calabro President and Chief Operating Officer | 450.0K | 477.0K | 4.21M | — | — | 9.0K | 5.14M | 81.80% | ↗ |
| 175 | 2005 | Roger J. Medel, M.D. Chief Executive Officer | 675.0K | 715.5K | 2.55M | — | — | 92.5K | 4.03M | 63.23% | ↗ |
| 176 | 2005 | Karl B. Wagner Chief Financial Officer and Treasurer | 375.0K | 397.5K | 3.16M | — | — | 9.0K | 3.94M | 80.15% | ↗ |
| 177 | 2005 | Thomas W. Hawkins Senior Vice President, General Counsel and Secretary | 350.0K | 371.0K | 1.28M | — | — | 546.00 | 2.00M | 63.86% | ↗ |
| 178 | 2004 | Roger J. Medel, M.D. Chief Executive Officer | 675.0K | 523.1K | — | — | — | 178.5K | 1.38M | 0.00% | ↗ |
| 179 | 2004 | Joseph M. Calabro President and Chief Operating Officer | 450.0K | 348.8K | — | — | — | 8.8K | 807.6K | 0.00% | ↗ |
| 180 | 2004 | Karl B. Wagner Chief Financial Officer and Treasurer | 375.0K | 290.6K | — | — | — | 8.8K | 674.4K | 0.00% | ↗ |
| 181 | 2004 | Thomas W. Hawkins Senior Vice President, General Counsel and Secretary | 350.0K | 271.3K | — | — | — | 546.00 | 621.8K | 0.00% | ↗ |
| 182 | 2003 | Roger J. Medel, M.D. Chief Executive Officer | 600.0K | 600.0K | — | — | — | 125.2K | 1.33M | 0.00% | ↗ |
| 183 | 2003 | Roger J. Medel, M.D. President and Chief Executive Officer | 600.0K | 600.0K | — | — | — | 81.3K | 1.28M | 0.00% | ↗ |
| 184 | 2003 | Joseph M. Calabro President and Chief Operating Officer | 350.0K | 500.0K | — | — | — | 8.7K | 858.7K | 0.00% | ↗ |
| 185 | 2003 | Joseph M. Calabro Chief Operating Officer | 350.0K | 500.0K | — | — | — | 8.7K | 858.7K | 0.00% | ↗ |
| 186 | 2003 | Karl B. Wagner Chief Financial Officer and Treasurer | 300.0K | 400.0K | — | — | — | 8.6K | 708.6K | 0.00% | ↗ |
| 187 | 2003 | Thomas W. Hawkins Senior Vice President, General Counsel and Secretary | 192.0K | 275.0K | — | — | — | 346.00 | 467.4K | 0.00% | ↗ |
| 188 | 2003 | Kristen Bratberg (Former President and Chief Executive Officer) | 142.0K | — | — | — | — | 213.7K | 355.6K | 0.00% | ↗ |
| 189 | 2003 | Brian T. Gillon (Former Executive Vice President — Corporate Development, General | 128.3K | — | — | — | — | 172.7K | 301.0K | 0.00% | ↗ |
| 190 | 2002 | Roger J. Medel, M.D., M.B.A. Chairman of the Board and Chief Executive Officer | 600.0K | 200.0K | — | — | — | 9.8K | 809.8K | 0.00% | ↗ |
| 191 | 2002 | Roger J. Medel, M.D. Chief Executive Officer | 600.0K | 200.0K | — | — | — | 8.8K | 808.8K | 0.00% | ↗ |
| 192 | 2002 | Roger J. Medel, M.D. President and Chief Executive Officer | 600.0K | 200.0K | — | — | — | 8.8K | 808.8K | 0.00% | ↗ |
| 193 | 2002 | Kristen Bratberg (Former President and Chief Executive Officer) | 400.0K | 400.0K | — | — | — | 8.4K | 808.4K | 0.00% | ↗ |
| 194 | 2002 | Kristen Bratberg President | 400.0K | 400.0K | — | — | — | 8.4K | 808.4K | 0.00% | ↗ |
| 195 | 2002 | Joseph M. Calabro Chief Operating Officer | 300.0K | 250.0K | — | — | — | 8.3K | 558.3K | 0.00% | ↗ |
| 196 | 2002 | Joseph M. Calabro President and Chief Operating Officer | 300.0K | 250.0K | — | — | — | 8.3K | 558.3K | 0.00% | ↗ |
| 197 | 2002 | Brian T. Gillon (Former Executive Vice President — Corporate Development, General | 300.0K | 200.0K | — | — | — | 8.3K | 508.3K | 0.00% | ↗ |
| 198 | 2002 | Brian T. Gillon Executive Vice President — Corporate Development, | 300.0K | 200.0K | — | — | — | 8.3K | 508.3K | 0.00% | ↗ |
| 199 | 2002 | Karl B. Wagner Chief Financial Officer and Treasurer | 275.0K | 225.0K | — | — | — | 8.2K | 508.2K | 0.00% | ↗ |
| 200 | 2002 | Thomas W. Hawkins Senior Vice President, General Counsel and Secretary | — | — | — | — | — | — | — | — | ↗ |
| 201 | 2001 | Roger J. Medel, M.D., M.B.A. Chairman of the Board and Chief Executive Officer | 600.0K | 100.0K | — | — | — | 6.9K | 706.9K | 0.00% | ↗ |
| 202 | 2001 | Roger J. Medel, M.D. President and Chief Executive Officer | 600.0K | 100.0K | — | — | — | 6.9K | 706.9K | 0.00% | ↗ |
| 203 | 2001 | Kristen Bratberg President | 400.0K | 200.0K | — | — | — | 5.5K | 605.5K | 0.00% | ↗ |
| 204 | 2001 | Kristen Bratberg (Former President and Chief Executive Officer) | 400.0K | 200.0K | — | — | — | 5.5K | 605.5K | 0.00% | ↗ |
| 205 | 2001 | Joseph M. Calabro Chief Operating Officer | 250.0K | 150.0K | — | — | — | 5.3K | 405.3K | 0.00% | ↗ |
| 206 | 2001 | Brian T. Gillon Executive Vice President — Corporate Development, | 250.0K | 150.0K | — | — | — | 5.3K | 405.3K | 0.00% | ↗ |
| 207 | 2001 | Brian T. Gillon (Former Executive Vice President — Corporate Development, General | 250.0K | 150.0K | — | — | — | 5.3K | 405.3K | 0.00% | ↗ |
| 208 | 2001 | Karl B. Wagner Chief Financial Officer and Treasurer | 225.0K | 125.0K | — | — | — | 5.3K | 355.3K | 0.00% | ↗ |
| 209 | 2001 | Thomas W. Hawkins Senior Vice President, General Counsel and Secretary | — | — | — | — | — | — | — | — | ↗ |
| 210 | 2000 | Roger J. Medel, M.D., M.B.A. Chairman of the Board and Chief Executive Officer | 400.0K | 100.0K | — | — | — | 4.4K | 504.4K | 0.00% | ↗ |
| 211 | 2000 | Kristen Bratberg President | 300.0K | 200.0K | — | — | — | 3.8K | 503.8K | 0.00% | ↗ |
| 212 | 2000 | Brian T. Gillon Executive Vice President — Corporate Development, | 200.0K | 125.0K | — | — | — | 3.5K | 328.5K | 0.00% | ↗ |
| 213 | 2000 | Joseph M. Calabro Chief Operating Officer | 193.3K | 100.0K | — | — | — | 3.6K | 296.9K | 0.00% | ↗ |
| 214 | 2000 | Karl B. Wagner Chief Financial Officer and Treasurer | 179.2K | 75.0K | — | — | — | 3.5K | 257.7K | 0.00% | ↗ |
Proxy statements
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Mark S. Ordan | Chief Executive Officer & Executive Chairman | 6M | male |
| D. Gregory Neeb | Executive Vice President and Chief Investment & Strategy Officer | 2M | male |
| Mary Ann E. Moore | Chief Administrative Officer, Executive Vice President, General Counsel & Secretary | 2M | female |
| Kasandra H. Rossi | Executive Vice President, Treasurer & Chief Financial Officer | 1M | female |
| John C. Pepia | Senior Vice President & Chief Accounting Officer | 931.2K | male |
| Cheryl VanPatten | Senior Vice President & Chief Information Officer | — | female |
| Nanette Sanders | Executive Vice President of National Operations | — | female |
| Debra McRoberts | Senior Vice President of People Services | — | female |
| Kevin Pitzer | President of West Division | — | male |
| Michael Dwyer | Chief Medical Officer of South Central Division | — | — |
| Mike Ashford | President of South Central Division | — | male |
No Senate trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for MD
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
